data_2kq5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kq5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.813 -0.44 . . . . 0.73 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.23 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 1.03 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.23 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.93 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.17 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.14 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.15 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.19 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.13 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.27 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.8 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.574 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.67 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.21 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 2.05 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.5 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.15 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 1.33 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.93 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.28 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.27 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.3 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 2.22 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.6 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.63 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.21 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 1.49 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.28 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.573 ' O ' HG11 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.97 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.28 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.39 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.56 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.24 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.21 111.065 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.17 110.262 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.21 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.3 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.6 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.32 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.99 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.56 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.72 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.125 -0.324 . . . . 0.73 110.125 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.23 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 1.03 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.23 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.93 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.17 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.14 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.15 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.19 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.13 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.27 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.8 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.67 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.21 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 2.05 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.5 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.15 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 1.33 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.93 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.38 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.28 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.27 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.3 110.859 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 2.22 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.6 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.18 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.63 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.21 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 1.49 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.28 111.724 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.509 ' O ' HG11 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.97 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.28 110.832 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.39 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.56 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.24 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.21 111.293 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.17 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.21 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.3 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.6 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.32 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.99 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.56 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.72 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 3.3 pm0 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.144 -0.317 . . . . 0.61 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.78 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 1.21 111.691 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.44 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.53 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.45 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.97 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.55 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.23 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 1.08 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.84 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 ' O ' HG13 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.96 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.15 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 1.09 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.47 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.53 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.42 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.51 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.77 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.3 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.15 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 1.01 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.7 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.4 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 2.52 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.33 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 1.19 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 1.13 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 1.02 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.81 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.501 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.2 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.14 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 1.47 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.46 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 1.22 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.48 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 2.37 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.55 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.52 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.47 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.93 112.603 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 2.04 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 1.05 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 1.07 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.231 0.104 0 N-CA-C 110.38 -0.23 . . . . 0.59 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.49 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.51 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.43 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.43 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.18 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.38 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.71 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.33 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.24 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.56 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.45 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.82 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.58 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 1.17 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.73 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.49 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 1.12 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.42 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.92 111.606 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.34 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.79 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 1.68 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.72 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.93 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.42 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 1.12 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.428 HG21 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 1.49 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.64 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 37' ' ' VAL . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 1.23 111.991 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.47 112.049 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.47 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.3 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.53 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.32 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.61 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.71 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.58 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HZ3' ' HG2' ' A' ' 47' ' ' LYS . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.94 112.759 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.44 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.32 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.85 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.68 0.276 . . . . 1.45 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 1.15 111.696 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.19 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.24 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.553 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 1.07 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.26 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.94 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.44 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.87 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.36 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.22 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.94 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.33 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.92 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.98 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.86 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.74 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.43 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.98 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.72 111.4 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.38 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.44 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.71 112.573 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.87 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.61 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.27 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.26 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.7 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.43 110.859 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.98 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.39 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 1.08 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 1.2 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.9 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 1.41 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.49 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.85 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.34 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.09 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.22 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.21 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 1.64 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.93 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.492 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.457 -0.572 . . . . 0.46 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.53 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.49 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.61 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.16 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 2.04 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.34 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.452 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 1.14 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.31 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.07 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 1.38 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 2.37 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.62 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 2.12 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.13 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.82 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 16' ' ' LEU . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.21 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.57 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.47 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 1.12 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.5 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.44 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.24 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.52 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.78 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 2.05 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.33 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 2.21 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.97 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.57 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.68 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.57 111.602 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.64 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.98 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.57 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.27 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 1.05 110.789 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.46 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.55 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.06 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.4 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.7 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 2.45 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.68 111.121 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.34 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.25 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.67 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.588 -0.153 . . . . 1.06 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.93 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.59 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.34 111.037 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.38 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.3 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.84 110.432 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.57 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 1.19 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 1.01 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.46 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 1.37 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.35 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.6 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 1.15 110.875 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.67 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.74 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.32 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.54 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.24 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.35 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.39 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.87 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.47 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.85 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.26 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 1.02 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 1.18 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.535 ' O ' HG11 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 1.02 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.72 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.11 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.13 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.23 111.566 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 1.03 110.538 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 2.42 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.5 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.5 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.54 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 2.31 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.84 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.655 0.264 . . . . 1.6 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.24 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.33 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.4 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.32 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.67 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.31 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 1.09 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.32 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.66 112.385 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.96 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.36 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.18 111.582 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 1.11 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.87 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 1.01 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.469 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.54 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.4 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 1.0 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.01 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.61 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.96 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.17 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 2.11 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.6 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 1.47 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.33 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.36 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.32 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 2.06 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91 112.532 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.95 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.57 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 1.08 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.3 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.27 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 1.34 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.24 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.3 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.93 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.85 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.246 -0.279 . . . . 0.71 110.246 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.98 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.49 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.23 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.35 111.302 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.4 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.75 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.91 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.15 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.36 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.84 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.38 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.97 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 2.18 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.47 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.61 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.49 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.95 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.82 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.31 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.47 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.29 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.19 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.16 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.46 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.56 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 2.21 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.34 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 1.08 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.17 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.86 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.18 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.43 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.31 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 1.01 110.154 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.26 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 2.16 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.41 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.57 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.81 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 2.4 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.29 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.13 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.4 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.997 -0.371 . . . . 1.26 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 1.04 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.418 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.49 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.21 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.42 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.25 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.69 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 1.18 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.85 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.22 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 1.2 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.22 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' LYS . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 1.09 110.612 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.5 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.39 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.98 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.42 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.81 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.64 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.29 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.48 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.23 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.39 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.55 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.86 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 1.14 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.48 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 2.15 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.687 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.2 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' O ' HG11 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 1.11 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.32 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.12 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.18 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 1.18 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.21 111.013 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.4 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.13 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.9 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.7 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.72 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.41 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.34 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 2.28 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.686 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 1.34 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 1.13 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.99 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.44 111.326 -179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.662 0.268 . . . . 1.23 110.361 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.38 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.53 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.434 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.36 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.6 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.42 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.48 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 1.11 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.51 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 1.32 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.52 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.85 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 1.33 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.59 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.9 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.23 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.36 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 17' ' ' GLU . 13.2 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.72 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.85 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.5 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 1.15 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.43 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 1.2 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.05 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.52 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.2 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 2.03 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 1.2 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 1.03 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' O ' HG11 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32 110.382 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.28 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.2 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.15 111.146 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 1.05 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.28 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.2 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.63 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 1.43 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 1.1 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.77 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 1.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.062 -0.348 . . . . 1.97 110.062 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.47 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 1.26 110.728 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.18 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.28 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.28 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.77 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 2.53 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.38 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HZ2' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.51 110.153 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.62 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.81 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CD ' ' HZ2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23 111.117 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.83 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.16 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.96 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.75 111.582 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.52 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.1 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.08 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.46 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 1.49 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.9 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.7 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.31 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.21 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.518 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' O ' HG11 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.29 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.96 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 1.37 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.41 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.15 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.21 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 1.1 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.35 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.31 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.45 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 2.52 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.8 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.62 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.57 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.69 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.508 -0.553 . . . . 1.97 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.47 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 1.26 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.18 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.28 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.77 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 2.53 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.38 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.51 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.62 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.81 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.446 HG21 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.83 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.16 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.96 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.75 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.52 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.5 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.541 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.1 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.08 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.46 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 1.49 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.9 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.7 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.31 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.21 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' O ' HG11 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.29 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.96 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 1.37 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.41 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.15 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.21 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 1.1 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.35 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.31 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.45 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 2.52 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.8 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.62 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.57 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.69 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.619 0.247 . . . . 0.66 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 1.22 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 1.09 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.54 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.69 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.37 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.38 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.39 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.74 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 1.4 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.521 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.94 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.85 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.25 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.63 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.9 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.65 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.44 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.97 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.93 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.29 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.35 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 1.01 111.644 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.34 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.37 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 1.09 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.77 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 1.46 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.73 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.3 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.36 110.931 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.49 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.52 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.34 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.17 111.502 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.1 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.06 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.42 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.77 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 2.31 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 1.29 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 1.45 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.33 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.598 0.237 . . . . 0.96 110.996 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 1.29 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.32 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.4 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.17 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' GLU . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.22 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.39 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.38 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.32 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.62 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.36 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 2.17 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.29 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 1.25 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.72 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 1.39 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.87 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.43 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.61 111.491 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 1.22 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.68 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.95 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 2.17 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 1.67 110.901 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 1.05 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.34 111.366 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.91 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.18 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.2 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.1 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.33 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.19 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.9 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.59 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.84 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.15 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 1.11 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.626 0.251 . . . . 0.96 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.986 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.503 HG12 ' HG ' ' A' ' 22' ' ' LEU . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.88 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 1.22 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.25 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.39 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.98 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.29 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.23 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 1.34 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39 112.486 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.88 110.729 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 1.32 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 2.1 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 1.03 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.32 111.486 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.503 ' HG ' HG12 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.35 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 1.06 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.35 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.48 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.96 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 1.06 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.85 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.55 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.42 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.36 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.72 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.76 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.21 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.32 110.593 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 33' ' ' THR . 4.4 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.63 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.6 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 1.5 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.28 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.9 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.36 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 1.26 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 1.39 110.828 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.46 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.7 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.3 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.48 109.987 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.32 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.02 -0.363 . . . . 1.9 110.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.55 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 1.18 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.3 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.32 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.46 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.88 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 1.14 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.3 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 1.58 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.57 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 1.11 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.36 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 2.08 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.34 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.67 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.12 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 1.15 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.36 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.21 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.54 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 1.63 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.38 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.87 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.11 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 1.0 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.24 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.521 ' O ' HG11 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.17 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.4 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.27 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 1.09 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 1.0 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.32 110.221 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.17 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.84 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.24 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.28 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 1.8 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.25 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.49 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.454 ' O ' HG12 ' A' ' 6' ' ' ILE . 15.3 pm0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.165 -0.309 . . . . 1.9 110.165 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.55 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.469 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 1.18 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.3 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.32 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.22 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.46 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.88 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 1.14 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.3 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 1.58 110.684 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.57 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 1.11 111.735 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.36 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 2.08 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.34 111.351 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 1.34 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.258 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.12 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 1.15 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.36 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.21 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.54 110.999 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 1.63 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.38 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.87 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.11 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 1.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.5 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.24 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.541 ' O ' HG11 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.17 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.4 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.27 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 1.09 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.0 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.32 109.706 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.84 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.24 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.28 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 1.8 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.25 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.49 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' H ' ' HB1' ' A' ' 5' ' ' ALA . 12.9 pt20 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.441 -0.948 . . . . 0.69 108.441 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.26 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.9 111.369 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.449 ' HB1' ' H ' ' A' ' 2' ' ' GLN . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.43 111.369 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 1.05 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.46 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.73 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.98 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.39 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.15 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.24 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.41 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.42 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 1.11 112.626 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.99 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.85 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 1.44 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.72 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.42 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 1.43 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.43 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.19 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.2 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.18 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.41 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.92 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.9 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 1.38 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.46 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.496 ' O ' HG11 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.27 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.47 110.885 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.58 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.24 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.58 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.51 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.8 110.937 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.35 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.18 110.798 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.58 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.39 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 1.15 110.893 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.87 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.606 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.98 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.32 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.13 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.08 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.1 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 1.02 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.14 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 1.17 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.61 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 19' ' ' VAL . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.86 111.8 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.24 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.86 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.19 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.45 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 1.12 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 1.29 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.86 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.08 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.19 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 1.48 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 2.0 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.38 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.38 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.8 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 1.8 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.3 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.25 112.149 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.29 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.09 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.36 112.77 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.36 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.28 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.35 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.32 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.61 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.61 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 1.82 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.08 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 1.01 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.43 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.98 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.32 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.13 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.08 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.1 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 1.02 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.14 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 1.0 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 1.17 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.61 112.544 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.86 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.86 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.19 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.45 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 1.12 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 1.29 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.86 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.08 112.528 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.19 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 1.48 111.031 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 2.0 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.38 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.38 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.8 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 1.8 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.411 HG23 HE21 ' A' ' 36' ' ' GLN . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.3 112.153 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' HG11 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.25 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.29 110.022 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.411 HE21 HG23 ' A' ' 33' ' ' THR . 9.7 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26 110.796 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.09 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.44 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.36 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.36 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.37 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.28 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.35 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.32 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.61 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.61 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 1.82 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.08 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 1.01 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.43 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.039 -0.356 . . . . 1.83 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -154.74 159.4 40.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.813 -0.44 . . . . 0.73 109.813 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.23 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 1.03 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.23 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.93 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.17 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.14 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.15 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.19 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.13 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.27 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.8 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.574 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.67 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.21 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 2.05 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.5 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.15 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 1.33 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.93 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.38 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.28 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.27 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.3 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 2.22 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.6 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.63 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.21 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 1.49 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.28 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.573 ' O ' HG11 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.97 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.28 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.39 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.56 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.24 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.21 111.065 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.17 110.262 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.21 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.3 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.6 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.32 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.99 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.56 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.72 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.774 0.321 . . . . 1.83 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -74.82 158.68 33.03 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.125 -0.324 . . . . 0.73 110.125 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.23 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 1.03 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.23 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.93 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.17 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.14 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.15 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.19 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.13 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.27 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.8 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' HG13 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.67 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.21 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 2.05 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.5 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.15 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 1.33 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.93 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.38 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.28 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.27 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.3 110.859 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 2.22 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.6 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.18 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.63 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.21 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 1.49 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.28 111.724 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.509 ' O ' HG11 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.97 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.28 110.832 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.39 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.56 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG11 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.24 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.21 111.293 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.17 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.21 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.3 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.6 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.32 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.99 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.56 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.72 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.807 0.337 . . . . 1.19 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 3.3 pm0 -89.84 177.95 6.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.854 -0.612 . . . . 0.61 110.144 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.78 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 1.21 111.691 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.44 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.53 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.45 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.97 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.55 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.23 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 1.08 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.84 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 ' O ' HG13 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.96 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.15 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 1.09 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.47 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.53 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.42 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.51 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.77 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.3 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.15 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 1.01 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.7 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.4 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 2.52 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.33 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 1.19 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 1.13 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 1.02 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.81 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.501 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.2 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.14 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 1.47 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.46 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 1.22 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.48 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 2.37 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.55 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.52 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.47 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.93 112.603 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 2.04 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 1.05 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 1.07 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.347 -0.242 . . . . 1.49 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.99 152.76 44.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 0.59 110.38 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.49 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.51 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.43 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.43 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.18 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.38 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.71 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.33 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.24 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.56 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.437 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.45 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.82 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.58 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 1.17 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.73 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.49 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 1.12 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.42 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.92 111.606 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.34 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.79 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG21 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 1.68 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.72 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.93 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.42 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 1.12 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.428 HG21 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 1.49 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.64 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 37' ' ' VAL . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 1.23 111.991 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' N ' ' HG3' ' A' ' 36' ' ' GLN . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.47 112.049 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.47 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.3 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.53 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.32 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.61 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.71 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.58 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HZ3' ' HG2' ' A' ' 47' ' ' LYS . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.94 112.759 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.44 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.32 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.85 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 121.065 0.459 . . . . 2.32 109.845 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -73.67 157.14 37.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.805 -0.634 . . . . 1.45 111.032 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 1.15 111.696 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.19 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.24 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.553 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 1.07 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.26 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.94 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.44 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.87 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.36 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.22 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.94 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.33 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.92 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.98 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.86 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.74 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.43 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.98 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.72 111.4 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.38 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.44 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.71 112.573 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.87 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.61 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.27 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.26 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.7 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.43 110.859 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.98 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.39 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 1.08 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 1.2 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.9 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 1.41 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.49 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.85 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.34 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.09 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.22 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.21 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 51' ' ' GLU . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 1.64 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.93 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.492 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.975 0.417 . . . . 1.38 110.558 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -117.53 159.2 23.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.46 109.457 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.53 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.49 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.61 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.16 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 2.04 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.34 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.452 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 1.14 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.31 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.07 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 1.38 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 2.37 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.62 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 2.12 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.13 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.82 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.463 HG11 ' O ' ' A' ' 16' ' ' LEU . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.21 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.57 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.47 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 1.12 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.5 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.44 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.24 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.52 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.78 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 2.05 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.33 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 2.21 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.97 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.57 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.68 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.57 111.602 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.64 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.98 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.57 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.27 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 1.05 110.789 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.46 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.55 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.06 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.4 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.7 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 2.45 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.68 111.121 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.34 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.25 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.67 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.165 -0.309 . . . . 1.45 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.32 176.89 7.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 1.06 110.588 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.93 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.59 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.34 111.037 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.38 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.3 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.84 110.432 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.57 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 1.19 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 1.01 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.46 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 1.37 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.35 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.6 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 1.15 110.875 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.67 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.74 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.32 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.54 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.24 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.35 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.39 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.87 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.47 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.85 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.26 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 1.02 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.436 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 1.18 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.535 ' O ' HG11 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 1.02 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.72 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.11 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.13 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.23 111.566 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 1.03 110.538 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 2.42 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.5 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.5 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.54 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 2.31 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.84 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.464 0.173 . . . . 1.42 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.61 150.13 32.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.655 0.264 . . . . 1.6 110.564 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.24 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.33 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.4 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.32 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.67 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.31 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 1.09 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.32 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.66 112.385 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.96 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.36 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.18 111.582 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 1.11 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.87 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 1.01 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.469 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.54 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.4 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 1.0 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.01 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.434 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.61 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.96 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.17 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 2.11 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.6 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 1.47 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.33 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.36 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.32 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 2.06 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91 112.532 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.95 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.57 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 1.08 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.3 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.27 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 1.34 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.24 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.3 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.93 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.85 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.705 0.288 . . . . 0.77 110.475 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -104.08 -171.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 0.71 110.246 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.98 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.49 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.23 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.35 111.302 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.4 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.75 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.91 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.15 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.36 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.84 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.38 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.97 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 2.18 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.47 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.61 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.49 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.95 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.82 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.31 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.47 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.29 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.19 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.16 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.46 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.56 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 2.21 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.34 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 1.08 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.17 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.86 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.18 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.43 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.31 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 1.01 110.154 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.26 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 2.16 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.41 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.57 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.81 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 2.4 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.29 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 1.13 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.4 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.334 -0.247 . . . . 1.77 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -149.41 149.76 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.997 -0.371 . . . . 1.26 109.997 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 1.04 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.49 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.21 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.42 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.25 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.69 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 1.18 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.85 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.22 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 1.2 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.22 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' LYS . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 1.09 110.612 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.5 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.39 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.98 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.42 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.81 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.64 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.29 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.48 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.23 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.39 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.55 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.86 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 1.14 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.48 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 2.15 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.687 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.2 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' O ' HG11 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 1.11 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.32 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.12 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.18 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.449 HG11 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 1.18 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.21 111.013 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.4 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.13 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.9 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.7 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.72 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.41 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.34 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 2.28 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.686 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 1.34 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 1.13 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.99 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.44 111.326 -179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.934 0.397 . . . . 1.52 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 -70.95 163.17 28.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.814 -0.63 . . . . 1.23 110.361 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.38 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.53 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.434 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.36 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.6 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.42 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.48 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 1.11 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.51 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 1.32 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.52 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.85 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 1.33 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.59 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.9 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.23 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.36 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 17' ' ' GLU . 13.2 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.72 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.85 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.5 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 1.15 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.43 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 1.2 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 2.05 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.52 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.2 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 2.03 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 1.2 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 1.03 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' O ' HG11 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32 110.382 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.28 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.2 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.15 111.146 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 1.05 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.28 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.2 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.63 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 1.43 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 1.1 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.77 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 1.23 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.299 0.571 . . . . 1.31 110.102 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -85.62 150.72 24.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.869 -0.605 . . . . 1.97 110.062 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.47 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 1.26 110.728 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.18 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.28 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.28 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.77 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 2.53 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.38 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.459 ' HZ2' ' CD ' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.51 110.153 -179.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.62 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.81 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' CD ' ' HZ2' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23 111.117 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.83 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.16 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.96 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.75 111.582 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.52 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.1 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.08 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.46 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 1.49 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.9 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.7 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.31 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.21 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.518 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' O ' HG11 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.29 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.96 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 1.37 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.41 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.15 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.21 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 1.1 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.35 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.31 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.45 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 2.52 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.8 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.62 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.57 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.69 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.805 0.336 . . . . 1.31 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -140.16 159.96 41.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.835 -0.62 . . . . 1.97 109.508 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.47 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 1.26 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.18 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.28 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.77 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 2.53 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.38 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.51 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.62 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.81 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.446 HG21 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.83 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.16 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.96 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.75 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.52 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.5 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.1 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.08 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.46 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 1.49 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.9 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.7 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.31 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.21 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.5 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' O ' HG11 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.29 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.5 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.96 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 1.37 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.414 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.41 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.15 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.21 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 1.1 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.35 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.31 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.45 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 2.52 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.8 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.62 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.57 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.69 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.932 0.396 . . . . 1.12 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -81.87 167.95 18.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.807 -0.633 . . . . 0.66 110.932 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 1.22 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 1.09 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.54 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.69 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.37 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.38 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.39 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.74 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 1.4 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.521 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.94 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.85 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.25 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.63 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.9 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.65 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.44 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.97 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.93 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.29 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.35 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 1.01 111.644 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.34 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.37 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 1.09 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.77 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 1.46 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.73 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.3 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.36 110.931 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.49 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.52 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.34 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.17 111.502 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.1 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.06 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.42 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.77 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 2.31 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 1.29 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 1.45 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.33 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.993 0.425 . . . . 1.51 110.48 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -74.11 174.16 9.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.96 110.996 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 1.29 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.32 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.4 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.17 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 17' ' ' GLU . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.22 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.39 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.38 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.32 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.62 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.36 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 2.17 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.29 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 1.25 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.72 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 1.39 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.87 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.43 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.61 111.491 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 1.22 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.68 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.95 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 2.17 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 1.67 110.901 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 1.05 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.34 111.366 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.91 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.18 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.2 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.1 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.33 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.19 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.9 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.59 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.84 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.15 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 1.11 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.91 0.386 . . . . 1.3 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.47 174.18 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.96 110.776 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.986 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.503 HG12 ' HG ' ' A' ' 22' ' ' LEU . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.88 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.549 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 1.22 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.25 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.39 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.98 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.29 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.23 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 13' ' ' LYS . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 1.34 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.37 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39 112.486 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.88 110.729 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 1.32 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 2.1 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 1.03 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.32 111.486 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.503 ' HG ' HG12 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.35 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 1.06 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.35 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.48 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.96 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 1.06 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.85 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.55 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.42 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.36 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.72 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.76 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.21 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.32 110.593 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 33' ' ' THR . 4.4 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.63 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.6 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 1.5 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.28 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.9 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.36 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 1.26 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 1.39 110.828 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.46 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.7 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.3 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.48 109.987 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.32 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.586 0.232 . . . . 2.19 110.7 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -150.03 153.29 36.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.02 -0.363 . . . . 1.9 110.02 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.419 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.55 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 1.18 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.3 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.32 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.46 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.88 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 1.14 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.3 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 1.58 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.57 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 1.11 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.36 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 2.08 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.34 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 1.34 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.67 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.12 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 1.15 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.36 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.21 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.54 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 1.63 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.38 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.87 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.11 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 1.0 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.24 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.521 ' O ' HG11 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.17 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.48 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.4 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.27 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 1.09 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 1.0 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.32 110.221 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.17 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.84 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.24 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.28 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 1.8 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.25 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.49 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.195 -0.298 . . . . 2.19 110.195 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.454 ' O ' HG12 ' A' ' 6' ' ' ILE . 15.3 pm0 -133.88 168.87 17.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.517 -0.31 . . . . 1.9 110.165 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.55 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.469 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 1.18 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.3 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.32 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.22 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.46 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.88 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 1.14 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.3 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 1.58 110.684 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.57 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 1.11 111.735 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.36 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 2.08 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.34 111.351 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 1.34 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.258 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.12 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 1.15 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.36 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.21 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.54 110.999 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 1.63 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.38 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.87 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.11 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 1.0 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.5 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.24 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.541 ' O ' HG11 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.17 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.4 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.27 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 1.09 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 1.0 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.32 109.706 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.84 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.24 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.28 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 1.8 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.25 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.49 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.928 0.394 . . . . 1.56 110.747 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' H ' ' HB1' ' A' ' 5' ' ' ALA . 12.9 pt20 -161.19 -174.86 4.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.441 -0.948 . . . . 0.69 108.441 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.26 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.9 111.369 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' HB1' ' H ' ' A' ' 2' ' ' GLN . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.43 111.369 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 1.05 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.46 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.73 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.98 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.39 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.15 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.24 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.41 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.42 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 1.11 112.626 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.646 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.99 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.85 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 1.44 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.72 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.42 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 1.43 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.43 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.19 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.2 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.18 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.41 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.92 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.9 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 1.38 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.46 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.496 ' O ' HG11 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.27 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.47 110.885 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.58 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.24 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.58 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.51 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.8 110.937 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.35 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.18 110.798 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.58 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.39 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 1.15 110.893 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.87 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.606 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.986 -0.376 . . . . 1.35 109.986 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -163.88 162.19 23.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.98 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.32 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.13 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.08 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.1 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 1.02 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.14 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 1.17 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.61 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HG13 ' A' ' 19' ' ' VAL . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.86 111.8 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.24 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.86 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.19 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.45 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 1.12 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 1.29 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.86 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.08 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.19 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 1.48 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 2.0 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.38 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.38 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.8 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 1.8 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.3 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.25 112.149 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.29 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.09 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.36 112.77 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.36 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.28 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.35 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.32 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.61 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.61 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 1.82 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.08 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 1.01 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.43 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.682 0.277 . . . . 1.35 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -167.44 153.19 7.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.98 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.32 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.13 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.08 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.1 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 1.02 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.14 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 1.0 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 1.17 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.61 112.544 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.86 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.86 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.19 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.45 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 1.12 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 1.29 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.86 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.08 112.528 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.19 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 1.48 111.031 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 2.0 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.38 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.38 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.8 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 1.8 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.411 HG23 HE21 ' A' ' 36' ' ' GLN . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.3 112.153 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' O ' HG11 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.25 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.29 110.022 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.411 HE21 HG23 ' A' ' 33' ' ' THR . 9.7 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26 110.796 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.09 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.44 HG11 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.36 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.36 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.37 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.28 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.35 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.32 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.61 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.61 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 1.82 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.08 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 1.01 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.43 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.813 -0.44 . . . . 0.25 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.20000000000000001 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.27000000000000002 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.14999999999999999 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.089999999999999997 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.14000000000000001 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17000000000000001 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.10000000000000001 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.14999999999999999 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.14000000000000001 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.089999999999999997 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.17000000000000001 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.66000000000000003 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.29 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.17000000000000001 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 1.21 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.35999999999999999 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.0800000000000001 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.93000000000000005 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.14000000000000001 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 33' ' ' THR . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.28000000000000003 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.23000000000000001 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.20000000000000001 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.22 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 1.0600000000000001 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.3300000000000001 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.17999999999999999 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.42999999999999999 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.19 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 0.71999999999999997 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 23' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.25 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.5 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.26000000000000001 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.38 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.46000000000000002 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.20000000000000001 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.17999999999999999 111.065 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 19' ' ' VAL . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.20999999999999999 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.29999999999999999 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.35999999999999999 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.26000000000000001 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.47 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.48999999999999999 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52000000000000002 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.70999999999999996 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.125 -0.324 . . . . 0.25 110.125 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.20000000000000001 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 0.27000000000000002 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.14999999999999999 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.089999999999999997 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.14000000000000001 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17000000000000001 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.10000000000000001 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.14999999999999999 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.14000000000000001 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.089999999999999997 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.17000000000000001 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.66000000000000003 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.29 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.17000000000000001 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 1.21 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.35999999999999999 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.0800000000000001 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.93000000000000005 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.14000000000000001 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 33' ' ' THR . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.28000000000000003 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.23000000000000001 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.20000000000000001 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.22 110.859 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 1.0600000000000001 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.3300000000000001 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.17999999999999999 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.42999999999999999 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.19 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 0.71999999999999997 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 23' ' ' LEU . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.25 111.724 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.5 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.26000000000000001 110.832 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.38 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.46000000000000002 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.20000000000000001 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.17999999999999999 111.293 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.16 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.20999999999999999 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.29999999999999999 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.35999999999999999 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.26000000000000001 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.47 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.48999999999999999 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52000000000000002 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.70999999999999996 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HG2' HG22 ' A' ' 4' ' ' VAL . 3.3 pm0 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.144 -0.317 . . . . 0.31 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.67000000000000004 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 2' ' ' GLN . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 0.59999999999999998 111.691 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.35999999999999999 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.47999999999999998 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.35999999999999999 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26000000000000001 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.96999999999999997 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.45000000000000001 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.20000000000000001 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 0.44 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.24 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.67000000000000004 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.1499999999999999 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 0.45000000000000001 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.46999999999999997 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.44 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.41999999999999998 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.47999999999999998 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.25 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.12 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 0.20000000000000001 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.25 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.34999999999999998 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64000000000000001 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 1.55 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.23999999999999999 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 0.39000000000000001 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 0.93999999999999995 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 0.65000000000000002 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.81 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.02 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.1399999999999999 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 0.70999999999999996 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.40000000000000002 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 0.29999999999999999 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.38 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33000000000000002 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 1.9199999999999999 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.5 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.47999999999999998 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.46999999999999997 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.2 112.603 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 1.48 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 0.93999999999999995 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 . . . . . 0 C--O 1.231 0.104 0 N-CA-C 110.38 -0.23 . . . . 0.54000000000000004 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.44 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.42999999999999999 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.37 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.34999999999999998 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.17000000000000001 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.1200000000000001 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.57999999999999996 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.23999999999999999 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.22 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.3300000000000001 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.29 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.57999999999999996 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 0.32000000000000001 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.2 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.98999999999999999 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.37 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.72999999999999998 111.606 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34000000000000002 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.23999999999999999 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.67000000000000004 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' SG ' HG23 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 0.83999999999999997 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.54 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.73999999999999999 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.1799999999999999 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33000000000000002 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.47999999999999998 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.555 HG23 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 0.77000000000000002 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.56000000000000005 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 0.93000000000000005 111.991 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.46999999999999997 112.049 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.39000000000000001 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.27000000000000002 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.45000000000000001 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.28000000000000003 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17000000000000001 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.42999999999999999 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.70999999999999996 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.28000000000000003 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.76000000000000001 112.759 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.21 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.25 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.70999999999999996 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.68 0.276 . . . . 1.0 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 6' ' ' ILE . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 0.51000000000000001 111.696 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.14999999999999999 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.23999999999999999 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 0.25 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.22 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.92000000000000004 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.1899999999999999 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.32000000000000001 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.16 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' HD12 ' A' ' 16' ' ' LEU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.27000000000000002 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.3300000000000001 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.40000000000000002 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.68000000000000005 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55000000000000004 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.71999999999999997 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.66000000000000003 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.32000000000000001 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.4299999999999999 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.596 ' HB3' HD23 ' A' ' 26' ' ' LEU . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.62 111.4 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.28000000000000003 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45000000000000001 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.33000000000000002 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 22' ' ' LEU . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.37 112.573 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.29999999999999999 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.24 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.22 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.0800000000000001 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.37 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.62 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.28000000000000003 110.859 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.81999999999999995 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 0.71999999999999997 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 0.96999999999999997 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.76000000000000001 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 0.53000000000000003 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.40000000000000002 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.84999999999999998 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.0900000000000001 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.13 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.20999999999999999 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 0.93999999999999995 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.9299999999999999 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39000000000000001 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 50' ' ' LEU . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 110.492 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.457 -0.572 . . . . 0.45000000000000001 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.40999999999999998 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.51000000000000001 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.1599999999999999 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 1.3799999999999999 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.29999999999999999 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 0.39000000000000001 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92000000000000004 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.17000000000000001 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.059999999999999998 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 0.66000000000000003 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 1.99 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.5 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 1.71 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.1299999999999999 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.20000000000000001 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.13 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.1200000000000001 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 0.34999999999999998 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.35999999999999999 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.17999999999999999 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.41999999999999998 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.39000000000000001 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.7 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.32000000000000001 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 1.8 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.80000000000000004 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.0900000000000001 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.53000000000000003 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.602 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.6399999999999999 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.97999999999999998 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.33000000000000002 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.22 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 HG11 ' A' ' 19' ' ' VAL . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.789 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.39000000000000001 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46000000000000002 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.52000000000000002 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0600000000000001 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.38 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.48999999999999999 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 1.98 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 3.8 tt0 -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.58999999999999997 111.121 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.28000000000000003 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.02 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.6699999999999999 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.588 -0.153 . . . . 1.0600000000000001 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.81000000000000005 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.58999999999999997 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.20000000000000001 111.037 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.35999999999999999 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.26000000000000001 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.57999999999999996 110.432 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33000000000000002 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.37 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52000000000000002 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 0.81000000000000005 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 0.83999999999999997 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.23000000000000001 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 0.81000000000000005 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.3500000000000001 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.1299999999999999 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 40' ' ' ILE . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 0.31 110.875 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.3600000000000001 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.23000000000000001 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD12 HG21 ' A' ' 33' ' ' THR . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.39000000000000001 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.23999999999999999 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.28000000000000003 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27000000000000002 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.3100000000000001 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.38 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.56000000000000005 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.23000000000000001 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.40000000000000002 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 23' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 0.32000000000000001 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.546 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 0.56999999999999995 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.71999999999999997 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.080000000000000002 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.12 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.19 111.566 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 19' ' ' VAL . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.26000000000000001 110.538 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27000000000000002 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 1.45 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28000000000000003 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27000000000000002 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34000000000000002 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.3100000000000001 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.21 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.42999999999999999 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 1.8600000000000001 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.3300000000000001 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.655 0.264 . . . . 1.45 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.32000000000000001 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66000000000000003 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.17999999999999999 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.28000000000000003 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.19 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.27000000000000002 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.22 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26000000000000001 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.26000000000000001 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 0.91000000000000003 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.3 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.6599999999999999 112.385 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.66000000000000003 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.3600000000000001 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.77000000000000002 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 15' ' ' ALA . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.34000000000000002 111.582 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 0.77000000000000002 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.70999999999999996 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 0.13 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.45000000000000001 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.40000000000000002 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 0.27000000000000002 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.78000000000000003 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.60999999999999999 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.79000000000000004 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.14999999999999999 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 1.1899999999999999 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.59999999999999998 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 0.68999999999999995 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.1699999999999999 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.3600000000000001 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.3200000000000001 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 1.55 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91000000000000003 112.532 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.79000000000000004 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.53000000000000003 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 0.40000000000000002 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.20000000000000001 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.0700000000000001 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 0.98999999999999999 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.27000000000000002 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.23999999999999999 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.1599999999999999 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 1.6599999999999999 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.78000000000000003 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.56000000000000005 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 8.1 pt20 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.246 -0.279 . . . . 0.62 110.246 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.37 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.48999999999999999 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.14999999999999999 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 2' ' ' GLN . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.32000000000000001 111.302 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.32000000000000001 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.66000000000000003 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.23000000000000001 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.14999999999999999 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.35999999999999999 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.65000000000000002 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.1799999999999999 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.96999999999999997 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 1.3899999999999999 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.46999999999999997 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.34999999999999998 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.40999999999999998 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.51000000000000001 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.4099999999999999 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.26000000000000001 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.32000000000000001 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.25 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.16 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.11 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.31 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.5 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 1.47 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39000000000000001 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.17999999999999999 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 0.22 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.14999999999999999 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.85999999999999999 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.1000000000000001 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.42999999999999999 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.19 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 19' ' ' VAL . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 0.31 110.154 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.20999999999999999 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 1.4299999999999999 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.40999999999999998 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.34999999999999998 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.6599999999999999 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 1.8200000000000001 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.17999999999999999 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.28999999999999998 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.3999999999999999 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.997 -0.371 . . . . 0.75 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 0.20000000000000001 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.429 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.48999999999999999 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.16 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.35999999999999999 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.23000000000000001 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.47999999999999998 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.80000000000000004 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.1299999999999999 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17000000000000001 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.17999999999999999 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.0900000000000001 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 0.17999999999999999 110.612 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.38 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.29999999999999999 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.429 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.34000000000000002 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.28999999999999998 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.8100000000000001 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.24 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.23000000000000001 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.35999999999999999 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.16 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.23000000000000001 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.5900000000000001 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.39000000000000001 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.02 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27000000000000002 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 1.3899999999999999 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.694 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.04 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 0.70999999999999996 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.3200000000000001 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.1200000000000001 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.16 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 0.20000000000000001 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.19 111.013 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.34000000000000002 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.12 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.5 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.702 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.60999999999999999 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.7200000000000002 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.40999999999999998 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.27000000000000002 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 1.71 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 0.83999999999999997 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.28999999999999998 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.98999999999999999 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 47' ' ' LYS . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.4399999999999999 111.326 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.662 0.268 . . . . 1.0 110.361 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.1000000000000001 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.28999999999999998 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.35999999999999999 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.53000000000000003 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.41999999999999998 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.47999999999999998 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 0.98999999999999999 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52000000000000002 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.26000000000000001 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 0.64000000000000001 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.51 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.22 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.90000000000000002 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.19 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.26000000000000001 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 17' ' ' GLU . 81.7 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.29 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.49 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.45000000000000001 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 0.48999999999999999 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.42999999999999999 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 0.35999999999999999 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 1.0800000000000001 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.40999999999999998 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.20000000000000001 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 1.4099999999999999 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34000000000000002 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 0.46000000000000002 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 0.27000000000000002 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17000000000000001 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32000000000000001 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.23999999999999999 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.13 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.14000000000000001 111.146 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.23000000000000001 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.23000000000000001 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.20000000000000001 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.53000000000000003 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91000000000000003 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34000000000000002 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.81000000000000005 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 0.78000000000000003 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.65000000000000002 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.46999999999999997 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76000000000000001 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.062 -0.348 . . . . 1.52 110.062 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.40999999999999998 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 21' ' ' ARG . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.42999999999999999 110.728 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.16 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.23000000000000001 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.23000000000000001 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.23999999999999999 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 1.78 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.28999999999999998 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34000000000000002 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.41999999999999998 110.153 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.57999999999999996 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93000000000000005 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.56000000000000005 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.117 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.17999999999999999 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.13 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.2999999999999998 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.46999999999999997 111.582 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.41999999999999998 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.436 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.37 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.10000000000000001 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.050000000000000003 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 0.25 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.77000000000000002 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65000000000000002 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.56000000000000005 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.28000000000000003 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.17999999999999999 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.28999999999999998 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27000000000000002 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.81999999999999995 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 0.56999999999999995 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.35999999999999999 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.14000000000000001 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.16 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39000000000000001 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 0.77000000000000002 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.34999999999999998 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.20999999999999999 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.31 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.63 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.53000000000000003 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.46000000000000002 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.6899999999999999 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.508 -0.553 . . . . 1.52 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.40999999999999998 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.42999999999999999 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.16 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.23000000000000001 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.23000000000000001 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.23999999999999999 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 1.78 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.28999999999999998 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34000000000000002 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.41999999999999998 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.57999999999999996 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93000000000000005 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.56000000000000005 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23000000000000001 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.17999999999999999 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.13 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.2999999999999998 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.46999999999999997 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.41999999999999998 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.37 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.10000000000000001 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.050000000000000003 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 0.25 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.77000000000000002 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65000000000000002 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.56000000000000005 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.28000000000000003 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.17999999999999999 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' O ' HG12 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.28999999999999998 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.81999999999999995 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.35999999999999999 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.14000000000000001 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.16 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39000000000000001 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 0.77000000000000002 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.34999999999999998 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.20999999999999999 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.31 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 1.6100000000000001 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.63 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.53000000000000003 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.46000000000000002 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.6899999999999999 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.619 0.247 . . . . 0.59999999999999998 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 0.51000000000000001 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 0.42999999999999999 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.48999999999999999 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.58999999999999997 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.26000000000000001 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.31 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.34000000000000002 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.57999999999999996 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 0.89000000000000001 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.4300000000000002 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.26000000000000001 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.34999999999999998 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.14999999999999999 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.57999999999999996 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.1799999999999999 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.11 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.03 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.26000000000000001 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.34999999999999998 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.20999999999999999 111.644 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.23999999999999999 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.34000000000000002 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.34999999999999998 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.63 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52000000000000002 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 0.68999999999999995 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.62 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.26000000000000001 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.35999999999999999 110.931 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.48999999999999999 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.42999999999999999 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.28999999999999998 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.14000000000000001 111.502 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.070000000000000007 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.059999999999999998 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33000000000000002 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81000000000000005 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.51000000000000001 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 1.4399999999999999 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65000000000000002 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 0.64000000000000001 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 0.53000000000000003 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.3300000000000001 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.598 0.237 . . . . 0.84999999999999998 110.996 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 0.48999999999999999 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54000000000000004 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.25 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.35999999999999999 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.14999999999999999 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.14000000000000001 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.28000000000000003 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.32000000000000001 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39000000000000001 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.22 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.39000000000000001 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.35999999999999999 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32000000000000001 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 1.7 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77000000000000002 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.28999999999999998 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.45000000000000001 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.60999999999999999 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.93999999999999995 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.75 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.35999999999999999 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39000000000000001 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.17000000000000001 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD13 ' A' ' 26' ' ' LEU . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.47999999999999998 111.491 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.58999999999999997 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.84999999999999998 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 1.48 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 35' ' ' GLU . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 0.76000000000000001 110.901 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 0.55000000000000004 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 33' ' ' THR . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.3400000000000001 111.366 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.22 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.14000000000000001 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.14999999999999999 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.089999999999999997 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.27000000000000002 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.14999999999999999 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.23000000000000001 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.54000000000000004 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.83999999999999997 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67000000000000004 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.1499999999999999 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81000000000000005 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 0.46000000000000002 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.626 0.251 . . . . 0.67000000000000004 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 4' ' ' VAL . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.56999999999999995 111.986 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 3' ' ' VAL . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.65000000000000002 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39000000000000001 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.58999999999999997 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45000000000000001 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.17999999999999999 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.34999999999999998 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.28 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.23999999999999999 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.17000000000000001 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 16' ' ' LEU . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 0.5 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39000000000000001 112.486 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 13' ' ' LYS . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.4199999999999999 110.729 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51000000000000001 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 0.41999999999999998 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 1.29 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 0.83999999999999997 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 111.486 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HG ' HG11 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.34999999999999998 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 0.78000000000000003 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.34999999999999998 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.38 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.32000000000000001 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 0.51000000000000001 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.76000000000000001 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.46999999999999997 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.04 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.35999999999999999 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.0 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.59999999999999998 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.19 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.3200000000000001 110.593 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' THR . 30.3 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.52000000000000002 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.59999999999999998 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 0.64000000000000001 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.26000000000000001 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.1899999999999999 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.31 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.94999999999999996 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.828 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67000000000000004 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.22 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.35999999999999999 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.03 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65000000000000002 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.47999999999999998 109.987 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.3200000000000001 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.02 -0.363 . . . . 1.8999999999999999 110.02 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.40999999999999998 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 0.65000000000000002 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.27000000000000002 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.20000000000000001 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.34999999999999998 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.70999999999999996 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.28999999999999998 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.29999999999999999 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.65000000000000002 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.55000000000000004 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34000000000000002 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 0.88 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.35999999999999999 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 1.23 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.27000000000000002 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.96999999999999997 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.57999999999999996 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.10000000000000001 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 0.69999999999999996 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.35999999999999999 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.16 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.41999999999999998 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.71999999999999997 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79000000000000004 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.32000000000000001 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.65000000000000002 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.080000000000000002 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 0.65000000000000002 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.20000000000000001 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.13 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.40000000000000002 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.23999999999999999 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 0.27000000000000002 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.17999999999999999 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 19' ' ' VAL . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.27000000000000002 110.221 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.12 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.69999999999999996 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.23999999999999999 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.25 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 0.98999999999999999 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.20000000000000001 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.544 ' N ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.165 -0.309 . . . . 1.8999999999999999 110.165 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.40999999999999998 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.65000000000000002 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.26000000000000001 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.27000000000000002 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.20000000000000001 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.34999999999999998 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.70999999999999996 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.28999999999999998 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.29999999999999999 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 0.65000000000000002 110.684 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.55000000000000004 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34000000000000002 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 13' ' ' LYS . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 0.88 111.735 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.35999999999999999 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.23 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 40' ' ' ILE . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.27000000000000002 111.351 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.96999999999999997 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' HG12 ' A' ' 4' ' ' VAL . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.57999999999999996 111.258 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.10000000000000001 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 0.69999999999999996 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.35999999999999999 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.16 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.41999999999999998 110.999 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.71999999999999997 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79000000000000004 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.32000000000000001 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.65000000000000002 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.080000000000000002 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 0.65000000000000002 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.516 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.20000000000000001 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.55 ' O ' HG12 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.13 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.40000000000000002 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.23999999999999999 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 0.27000000000000002 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 0.17999999999999999 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 HG11 ' A' ' 19' ' ' VAL . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.27000000000000002 109.706 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.12 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.69999999999999996 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.23999999999999999 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.25 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 0.98999999999999999 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.20000000000000001 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.42999999999999999 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.558 ' HG3' HG22 ' A' ' 4' ' ' VAL . 12.9 pt20 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.441 -0.948 . . . . 0.68000000000000005 108.441 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.22 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 2' ' ' GLN . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.90000000000000002 111.369 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.17000000000000001 111.369 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 0.35999999999999999 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.39000000000000001 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.72999999999999998 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.87 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.34999999999999998 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.14999999999999999 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.23999999999999999 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.5 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.1000000000000001 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 0.58999999999999997 112.626 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.26 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.1499999999999999 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 0.71999999999999997 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.27 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.02 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 0.53000000000000003 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.33000000000000002 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.17000000000000001 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.17999999999999999 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.11 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.13 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46000000000000002 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.65000000000000002 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32000000000000001 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 0.45000000000000001 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.40000000000000002 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.22 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.608 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.46999999999999997 110.885 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.23999999999999999 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.46000000000000002 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.42999999999999999 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 19' ' ' VAL . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.68999999999999995 110.937 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46000000000000002 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.798 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.57999999999999996 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.31 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.93000000000000005 110.893 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.46999999999999997 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.51000000000000001 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.4199999999999999 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.16 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.20000000000000001 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.089999999999999997 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.050000000000000003 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.089999999999999997 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 0.78000000000000003 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.23999999999999999 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.12 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 0.92000000000000004 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.60999999999999999 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.56000000000000005 111.8 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.23999999999999999 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.05 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.17000000000000001 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.40999999999999998 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 0.84999999999999998 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 0.34999999999999998 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.54000000000000004 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.080000000000000002 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.17999999999999999 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.59999999999999998 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 0.77000000000000002 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.28999999999999998 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.48999999999999999 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 0.88 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.25 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 38' ' ' VAL . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.20999999999999999 112.149 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.26000000000000001 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26000000000000001 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.070000000000000007 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.29999999999999999 112.77 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.32000000000000001 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.31 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.20000000000000001 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.33000000000000002 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.04 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.6100000000000001 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.47999999999999998 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65000000000000002 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 0.89000000000000001 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.0800000000000001 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 0.81000000000000005 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.4299999999999999 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.16 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.20000000000000001 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.089999999999999997 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.050000000000000003 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.089999999999999997 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.78000000000000003 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.23999999999999999 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.12 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 0.37 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.92000000000000004 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 43' ' ' HIS . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.60999999999999999 112.544 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.56000000000000005 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.23999999999999999 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.05 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.17000000000000001 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.40999999999999998 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 0.84999999999999998 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 0.34999999999999998 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.54000000000000004 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.080000000000000002 112.528 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.17999999999999999 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 0.59999999999999998 111.031 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.77000000000000002 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.2 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.28999999999999998 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.48999999999999999 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 0.88 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.25 112.153 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.20999999999999999 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 19' ' ' VAL . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 110.022 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26000000000000001 110.796 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.070000000000000007 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.29999999999999999 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.32000000000000001 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.20000000000000001 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.33000000000000002 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.04 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.6100000000000001 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.47999999999999998 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65000000000000002 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 0.89000000000000001 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.0800000000000001 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 0.81000000000000005 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.4299999999999999 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.039 -0.356 . . . . 1.8300000000000001 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -154.74 159.4 40.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.813 -0.44 . . . . 0.25 109.813 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.20000000000000001 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.27000000000000002 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.14999999999999999 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.089999999999999997 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.14000000000000001 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17000000000000001 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.10000000000000001 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.14999999999999999 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.14000000000000001 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.089999999999999997 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.17000000000000001 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.66000000000000003 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.29 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.17000000000000001 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 1.21 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.35999999999999999 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.0800000000000001 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.93000000000000005 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.14000000000000001 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 33' ' ' THR . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.28000000000000003 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.23000000000000001 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.20000000000000001 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.22 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 1.0600000000000001 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.3300000000000001 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.17999999999999999 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.42999999999999999 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.19 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 0.71999999999999997 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 23' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.25 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.5 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.26000000000000001 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.38 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.46000000000000002 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.20000000000000001 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.17999999999999999 111.065 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 19' ' ' VAL . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.20999999999999999 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.29999999999999999 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.35999999999999999 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.26000000000000001 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.47 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.48999999999999999 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52000000000000002 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.70999999999999996 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.774 0.321 . . . . 1.8300000000000001 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -74.82 158.68 33.03 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.125 -0.324 . . . . 0.25 110.125 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.20000000000000001 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 0.27000000000000002 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.14999999999999999 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.089999999999999997 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.14000000000000001 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17000000000000001 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.10000000000000001 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.14999999999999999 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.14000000000000001 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.089999999999999997 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.17000000000000001 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.66000000000000003 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.29 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.17000000000000001 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 1.21 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.35999999999999999 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.0800000000000001 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.93000000000000005 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.14000000000000001 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 33' ' ' THR . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.28000000000000003 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.23000000000000001 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.20000000000000001 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.22 110.859 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 1.0600000000000001 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.3300000000000001 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.17999999999999999 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.42999999999999999 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.19 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 0.71999999999999997 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 23' ' ' LEU . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.25 111.724 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.5 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.26000000000000001 110.832 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.38 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.46000000000000002 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.20000000000000001 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.17999999999999999 111.293 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.16 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.20999999999999999 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.29999999999999999 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.35999999999999999 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.26000000000000001 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.47 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.48999999999999999 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52000000000000002 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.70999999999999996 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.807 0.337 . . . . 1.1899999999999999 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HG2' HG22 ' A' ' 4' ' ' VAL . 3.3 pm0 -89.84 177.95 6.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.854 -0.612 . . . . 0.31 110.144 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.67000000000000004 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 2' ' ' GLN . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 0.59999999999999998 111.691 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.35999999999999999 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.47999999999999998 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.35999999999999999 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26000000000000001 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.96999999999999997 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.45000000000000001 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.20000000000000001 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 0.44 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.24 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.67000000000000004 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.1499999999999999 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 0.45000000000000001 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.46999999999999997 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.44 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.41999999999999998 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.47999999999999998 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.25 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.12 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 0.20000000000000001 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.25 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.34999999999999998 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64000000000000001 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 1.55 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.23999999999999999 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 0.39000000000000001 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 0.93999999999999995 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 0.65000000000000002 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.56999999999999995 110.81 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.02 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.1399999999999999 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 0.70999999999999996 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.40000000000000002 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 0.29999999999999999 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.38 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33000000000000002 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 1.9199999999999999 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.5 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.47999999999999998 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.46999999999999997 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.2 112.603 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 1.48 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.89000000000000001 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 0.93999999999999995 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.347 -0.242 . . . . 1.1000000000000001 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -69.99 152.76 44.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 0.54000000000000004 110.38 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.44 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.42999999999999999 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.37 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.34999999999999998 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.17000000000000001 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.1200000000000001 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.57999999999999996 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.23999999999999999 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.22 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.48999999999999999 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.3300000000000001 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.29 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.57999999999999996 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 0.32000000000000001 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.1000000000000001 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.2 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.98999999999999999 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.37 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.72999999999999998 111.606 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34000000000000002 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.23999999999999999 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.67000000000000004 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' SG ' HG23 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 0.83999999999999997 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.54 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.73999999999999999 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.1799999999999999 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33000000000000002 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.47999999999999998 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.555 HG23 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 0.77000000000000002 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.56000000000000005 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 0.93000000000000005 111.991 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.46999999999999997 112.049 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.39000000000000001 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.27000000000000002 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.45000000000000001 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.28000000000000003 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17000000000000001 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.42999999999999999 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.70999999999999996 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.28000000000000003 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.76000000000000001 112.759 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.21 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.25 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.70999999999999996 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 121.065 0.459 . . . . 2.3199999999999998 109.845 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -73.67 157.14 37.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.032 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 6' ' ' ILE . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 0.51000000000000001 111.696 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.14999999999999999 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.23999999999999999 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 0.25 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.22 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.92000000000000004 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.1899999999999999 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.76000000000000001 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.32000000000000001 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.16 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' HD12 ' A' ' 16' ' ' LEU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.27000000000000002 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.3300000000000001 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.40000000000000002 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.68000000000000005 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55000000000000004 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.71999999999999997 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.66000000000000003 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.32000000000000001 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.4299999999999999 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.596 ' HB3' HD23 ' A' ' 26' ' ' LEU . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.62 111.4 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.28000000000000003 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45000000000000001 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.33000000000000002 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 22' ' ' LEU . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.37 112.573 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.29999999999999999 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.24 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.22 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.0800000000000001 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.37 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.62 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.28000000000000003 110.859 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.81999999999999995 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 0.71999999999999997 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 0.96999999999999997 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.76000000000000001 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 0.53000000000000003 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.40000000000000002 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.84999999999999998 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.0900000000000001 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.13 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.20999999999999999 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 0.93999999999999995 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.9299999999999999 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39000000000000001 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 50' ' ' LEU . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 0.71999999999999997 110.492 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.975 0.417 . . . . 1.3799999999999999 110.558 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -117.53 159.2 23.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.45000000000000001 109.457 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.40999999999999998 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.51000000000000001 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.1599999999999999 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 1.3799999999999999 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.29999999999999999 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 0.39000000000000001 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92000000000000004 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.17000000000000001 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.059999999999999998 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 0.66000000000000003 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 1.99 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.5 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 1.71 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.1299999999999999 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.20000000000000001 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.13 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.1200000000000001 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 0.34999999999999998 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.35999999999999999 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.17999999999999999 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.41999999999999998 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.39000000000000001 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.7 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.32000000000000001 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 1.8 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.80000000000000004 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.0900000000000001 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.53000000000000003 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.5700000000000001 111.602 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.6399999999999999 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.97999999999999998 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.33000000000000002 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.22 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 HG11 ' A' ' 19' ' ' VAL . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.789 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.39000000000000001 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46000000000000002 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.52000000000000002 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.0600000000000001 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.38 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.48999999999999999 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 1.98 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 3.8 tt0 -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.58999999999999997 111.121 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.28000000000000003 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.02 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.6699999999999999 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.165 -0.309 . . . . 1.45 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.32 176.89 7.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 1.0600000000000001 110.588 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.81000000000000005 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.58999999999999997 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.20000000000000001 111.037 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.35999999999999999 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.26000000000000001 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.57999999999999996 110.432 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33000000000000002 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.37 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52000000000000002 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 0.81000000000000005 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 0.83999999999999997 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.23000000000000001 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 0.81000000000000005 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.3500000000000001 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.1299999999999999 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 40' ' ' ILE . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 0.31 110.875 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.3600000000000001 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.56999999999999995 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.23000000000000001 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD12 HG21 ' A' ' 33' ' ' THR . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.39000000000000001 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.23999999999999999 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.28000000000000003 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.33000000000000002 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27000000000000002 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.3100000000000001 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.38 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.56000000000000005 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.23000000000000001 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.40000000000000002 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 23' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 0.32000000000000001 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.546 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 0.56999999999999995 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.71999999999999997 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.080000000000000002 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.12 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.19 111.566 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 19' ' ' VAL . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.26000000000000001 110.538 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27000000000000002 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 1.45 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28000000000000003 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27000000000000002 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34000000000000002 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.3100000000000001 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.21 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.42999999999999999 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 1.8600000000000001 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.3300000000000001 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.464 0.173 . . . . 0.72999999999999998 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.61 150.13 32.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.655 0.264 . . . . 1.45 110.564 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.32000000000000001 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66000000000000003 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.17999999999999999 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.28000000000000003 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.19 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.27000000000000002 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.22 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26000000000000001 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.26000000000000001 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 0.91000000000000003 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.3 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.6599999999999999 112.385 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.66000000000000003 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.3600000000000001 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.77000000000000002 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 15' ' ' ALA . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.34000000000000002 111.582 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 0.77000000000000002 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.70999999999999996 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 0.13 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.45000000000000001 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.40000000000000002 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 0.27000000000000002 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.78000000000000003 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.60999999999999999 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.79000000000000004 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.14999999999999999 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 1.1899999999999999 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.59999999999999998 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 0.68999999999999995 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.1699999999999999 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.3600000000000001 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.3200000000000001 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 1.55 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91000000000000003 112.532 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.79000000000000004 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.53000000000000003 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 0.40000000000000002 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.20000000000000001 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.0700000000000001 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 0.98999999999999999 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.27000000000000002 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.23999999999999999 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.1599999999999999 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 1.6599999999999999 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.78000000000000003 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.56000000000000005 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.705 0.288 . . . . 0.77000000000000002 110.475 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 8.1 pt20 -104.08 -171.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.246 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.37 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.48999999999999999 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.14999999999999999 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 2' ' ' GLN . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.32000000000000001 111.302 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.32000000000000001 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.66000000000000003 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.23000000000000001 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.14999999999999999 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.35999999999999999 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.65000000000000002 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.1799999999999999 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.96999999999999997 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 1.3899999999999999 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.46999999999999997 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.34999999999999998 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.40999999999999998 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.51000000000000001 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HE ' ' HA ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.4099999999999999 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.26000000000000001 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.32000000000000001 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.25 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.16 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.11 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.31 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.5 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 1.47 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39000000000000001 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.17999999999999999 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 0.22 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.14999999999999999 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.85999999999999999 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.1000000000000001 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.42999999999999999 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.19 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 19' ' ' VAL . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 0.31 110.154 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.20999999999999999 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 1.4299999999999999 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.40999999999999998 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.34999999999999998 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.6599999999999999 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 1.8200000000000001 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.17999999999999999 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.28999999999999998 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.3999999999999999 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.334 -0.247 . . . . 0.88 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -149.41 149.76 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.997 -0.371 . . . . 0.75 109.997 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 0.20000000000000001 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.48999999999999999 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.16 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.35999999999999999 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.23000000000000001 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.47999999999999998 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.80000000000000004 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.1299999999999999 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17000000000000001 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.17999999999999999 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 0.34000000000000002 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.0900000000000001 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 0.17999999999999999 110.612 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.38 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.29999999999999999 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.429 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.34000000000000002 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.28999999999999998 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.8100000000000001 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.24 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.23000000000000001 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.35999999999999999 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.16 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.27000000000000002 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.23000000000000001 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.5900000000000001 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.39000000000000001 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.02 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27000000000000002 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 1.3899999999999999 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.694 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.04 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 0.70999999999999996 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.3200000000000001 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.1200000000000001 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.16 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 0.20000000000000001 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.19 111.013 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.34000000000000002 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.12 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.5 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.702 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.60999999999999999 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.7200000000000002 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.40999999999999998 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.27000000000000002 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 1.71 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 0.83999999999999997 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.28999999999999998 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.98999999999999999 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 47' ' ' LYS . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.4399999999999999 111.326 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.934 0.397 . . . . 1.52 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 -70.95 163.17 28.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.361 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.1000000000000001 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.28999999999999998 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.35999999999999999 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.53000000000000003 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.41999999999999998 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.47999999999999998 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 0.98999999999999999 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52000000000000002 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.26000000000000001 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 0.64000000000000001 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.51 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.22 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.90000000000000002 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.19 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.26000000000000001 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' OE1' ' HA ' ' A' ' 17' ' ' GLU . 81.7 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.29 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.49 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.45000000000000001 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 0.48999999999999999 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.42999999999999999 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 0.35999999999999999 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 1.0800000000000001 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.40999999999999998 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.20000000000000001 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 1.4099999999999999 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34000000000000002 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 0.46000000000000002 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 0.27000000000000002 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17000000000000001 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32000000000000001 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.23999999999999999 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.13 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.14000000000000001 111.146 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.23000000000000001 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.23000000000000001 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.20000000000000001 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.53000000000000003 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91000000000000003 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34000000000000002 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.81000000000000005 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 0.78000000000000003 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.65000000000000002 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.46999999999999997 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76000000000000001 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.299 0.571 . . . . 1.3100000000000001 110.102 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -85.62 150.72 24.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.869 -0.605 . . . . 1.52 110.062 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.40999999999999998 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 21' ' ' ARG . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.42999999999999999 110.728 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.16 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.23000000000000001 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.23000000000000001 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.23999999999999999 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 1.78 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.28999999999999998 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34000000000000002 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.41999999999999998 110.153 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.57999999999999996 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93000000000000005 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.56000000000000005 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.117 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.17999999999999999 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.13 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.2999999999999998 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.46999999999999997 111.582 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.41999999999999998 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.37 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.10000000000000001 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.050000000000000003 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 0.25 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.77000000000000002 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65000000000000002 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.56000000000000005 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.28000000000000003 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.17999999999999999 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.28999999999999998 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27000000000000002 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.81999999999999995 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 0.56999999999999995 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.35999999999999999 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.14000000000000001 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.16 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39000000000000001 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 0.77000000000000002 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.34999999999999998 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.20999999999999999 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.31 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 1.6100000000000001 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.63 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.53000000000000003 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.46000000000000002 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.6899999999999999 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.805 0.336 . . . . 1.3100000000000001 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -140.16 159.96 41.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.835 -0.62 . . . . 1.52 109.508 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.40999999999999998 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.42999999999999999 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.16 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.23000000000000001 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.23000000000000001 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.23999999999999999 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 1.78 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.28999999999999998 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34000000000000002 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.41999999999999998 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.57999999999999996 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93000000000000005 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.56000000000000005 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23000000000000001 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.17999999999999999 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.13 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.2999999999999998 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.46999999999999997 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.41999999999999998 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.37 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.10000000000000001 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.050000000000000003 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 0.25 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.77000000000000002 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65000000000000002 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.56000000000000005 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.28000000000000003 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.17999999999999999 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' O ' HG12 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.28999999999999998 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27000000000000002 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.81999999999999995 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.56999999999999995 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.35999999999999999 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.14000000000000001 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.16 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39000000000000001 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 0.77000000000000002 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.34999999999999998 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.20999999999999999 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.31 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 1.6100000000000001 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.63 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.53000000000000003 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.46000000000000002 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.6899999999999999 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.932 0.396 . . . . 1.0 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.415 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.1 pm0 -81.87 167.95 18.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.807 -0.633 . . . . 0.59999999999999998 110.932 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 0.51000000000000001 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 0.42999999999999999 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.48999999999999999 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.58999999999999997 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.26000000000000001 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.31 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.34000000000000002 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.57999999999999996 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45000000000000001 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 0.89000000000000001 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.4300000000000002 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.26000000000000001 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.34999999999999998 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.14999999999999999 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.57999999999999996 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.1799999999999999 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.11 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.03 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.26000000000000001 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.34999999999999998 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.20999999999999999 111.644 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.23999999999999999 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.34000000000000002 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.34999999999999998 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.63 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52000000000000002 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 0.68999999999999995 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.62 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.26000000000000001 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.35999999999999999 110.931 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.48999999999999999 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.42999999999999999 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.28999999999999998 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.14000000000000001 111.502 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.070000000000000007 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.059999999999999998 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33000000000000002 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81000000000000005 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.51000000000000001 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 1.4399999999999999 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65000000000000002 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 0.64000000000000001 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 0.53000000000000003 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.3300000000000001 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.993 0.425 . . . . 1.51 110.48 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -74.11 174.16 9.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.84999999999999998 110.996 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 0.48999999999999999 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54000000000000004 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.25 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.35999999999999999 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.14999999999999999 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.14000000000000001 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.28000000000000003 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.32000000000000001 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39000000000000001 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.22 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.39000000000000001 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.35999999999999999 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32000000000000001 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 1.7 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77000000000000002 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.28999999999999998 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.45000000000000001 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.60999999999999999 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.93999999999999995 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.75 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.35999999999999999 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39000000000000001 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.17000000000000001 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' HA ' HD13 ' A' ' 26' ' ' LEU . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.47999999999999998 111.491 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.98999999999999999 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.58999999999999997 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.84999999999999998 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 1.48 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 35' ' ' GLU . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 0.76000000000000001 110.901 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 0.55000000000000004 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 33' ' ' THR . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.3400000000000001 111.366 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.22 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.14000000000000001 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.14999999999999999 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.089999999999999997 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.27000000000000002 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.14999999999999999 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.23000000000000001 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.54000000000000004 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.83999999999999997 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67000000000000004 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.1499999999999999 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81000000000000005 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 0.46000000000000002 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.91 0.386 . . . . 1.3 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.47 174.18 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.67000000000000004 110.776 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 4' ' ' VAL . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.56999999999999995 111.986 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 3' ' ' VAL . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.65000000000000002 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39000000000000001 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.58999999999999997 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45000000000000001 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.17999999999999999 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.34999999999999998 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.28 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.23999999999999999 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.17000000000000001 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 16' ' ' LEU . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 0.5 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39000000000000001 112.486 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 13' ' ' LYS . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.4199999999999999 110.729 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51000000000000001 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 0.41999999999999998 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 1.29 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 0.83999999999999997 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.1499999999999999 111.486 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HG ' HG11 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.34999999999999998 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 0.78000000000000003 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.34999999999999998 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.38 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.32000000000000001 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 0.51000000000000001 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.76000000000000001 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.46999999999999997 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.04 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.35999999999999999 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.0 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.59999999999999998 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.19 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.3200000000000001 110.593 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' THR . 30.3 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.52000000000000002 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.59999999999999998 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 0.64000000000000001 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.26000000000000001 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.1899999999999999 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.31 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.94999999999999996 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.828 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67000000000000004 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.22 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.35999999999999999 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.03 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65000000000000002 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.47999999999999998 109.987 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.3200000000000001 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.586 0.232 . . . . 2.1899999999999999 110.7 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -150.03 153.29 36.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.02 -0.363 . . . . 1.8999999999999999 110.02 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.40999999999999998 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 0.65000000000000002 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.27000000000000002 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.20000000000000001 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.34999999999999998 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.70999999999999996 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.28999999999999998 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.29999999999999999 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.65000000000000002 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.55000000000000004 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34000000000000002 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 0.88 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.35999999999999999 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 1.23 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.27000000000000002 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.96999999999999997 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.57999999999999996 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.10000000000000001 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 0.69999999999999996 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.35999999999999999 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.16 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.41999999999999998 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.71999999999999997 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79000000000000004 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.32000000000000001 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.65000000000000002 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.080000000000000002 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 0.65000000000000002 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.20000000000000001 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.13 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.40000000000000002 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.23999999999999999 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 0.27000000000000002 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.17999999999999999 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 19' ' ' VAL . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.27000000000000002 110.221 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.12 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.69999999999999996 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.23999999999999999 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.25 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 0.98999999999999999 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.20000000000000001 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.42999999999999999 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.195 -0.298 . . . . 2.1899999999999999 110.195 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 6' ' ' ILE . 15.3 pm0 -133.88 168.87 17.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.517 -0.31 . . . . 1.8999999999999999 110.165 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.40999999999999998 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.65000000000000002 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.26000000000000001 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.27000000000000002 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.20000000000000001 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.34999999999999998 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.70999999999999996 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.28999999999999998 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.29999999999999999 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 0.65000000000000002 110.684 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.55000000000000004 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34000000000000002 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 13' ' ' LYS . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 0.88 111.735 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.35999999999999999 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.23 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 40' ' ' ILE . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.27000000000000002 111.351 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.96999999999999997 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' HG12 ' A' ' 4' ' ' VAL . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.57999999999999996 111.258 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.10000000000000001 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 0.69999999999999996 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.35999999999999999 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.16 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.41999999999999998 110.999 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.71999999999999997 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79000000000000004 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.32000000000000001 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.65000000000000002 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.080000000000000002 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 0.65000000000000002 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.516 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.20000000000000001 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.55 ' O ' HG12 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.13 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.40000000000000002 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.23999999999999999 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 0.27000000000000002 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 0.17999999999999999 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 HG11 ' A' ' 19' ' ' VAL . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.27000000000000002 109.706 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.12 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.69999999999999996 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.23999999999999999 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.25 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 0.98999999999999999 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.20000000000000001 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.42999999999999999 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.928 0.394 . . . . 1.23 110.747 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.716 ' H ' ' HB3' ' A' ' 5' ' ' ALA . 12.9 pt20 -161.19 -174.86 4.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.441 -0.948 . . . . 0.68000000000000005 108.441 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.22 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 2' ' ' GLN . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.90000000000000002 111.369 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 2' ' ' GLN . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.17000000000000001 111.369 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 0.35999999999999999 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.39000000000000001 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.72999999999999998 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.87 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.34999999999999998 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.14999999999999999 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.23999999999999999 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.5 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.1000000000000001 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 0.58999999999999997 112.626 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.26 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.1499999999999999 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 0.71999999999999997 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.27 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.02 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 0.53000000000000003 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.33000000000000002 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.17000000000000001 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.17999999999999999 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.11 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.13 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46000000000000002 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.65000000000000002 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32000000000000001 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 0.45000000000000001 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.40000000000000002 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.22 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.608 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.46999999999999997 110.885 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.23999999999999999 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.46000000000000002 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.42999999999999999 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 19' ' ' VAL . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.68999999999999995 110.937 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46000000000000002 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.798 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.57999999999999996 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.31 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.93000000000000005 110.893 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.46999999999999997 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.51000000000000001 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.4199999999999999 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.986 -0.376 . . . . 1.3500000000000001 109.986 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -163.88 162.19 23.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.16 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.20000000000000001 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.089999999999999997 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.050000000000000003 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.089999999999999997 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 0.78000000000000003 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.23999999999999999 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.12 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 0.92000000000000004 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.60999999999999999 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.56000000000000005 111.8 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.23999999999999999 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.05 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.17000000000000001 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.40999999999999998 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 0.84999999999999998 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 0.34999999999999998 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.54000000000000004 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.080000000000000002 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.17999999999999999 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.59999999999999998 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 0.77000000000000002 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.28999999999999998 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.48999999999999999 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 0.88 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.25 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 38' ' ' VAL . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.20999999999999999 112.149 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.26000000000000001 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26000000000000001 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.070000000000000007 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.29999999999999999 112.77 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.32000000000000001 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.31 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.20000000000000001 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.33000000000000002 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.04 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.6100000000000001 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.47999999999999998 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65000000000000002 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 0.89000000000000001 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.0800000000000001 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 0.81000000000000005 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.4299999999999999 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.682 0.277 . . . . 1.3500000000000001 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -167.44 153.19 7.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.16 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.20000000000000001 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.089999999999999997 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.050000000000000003 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.089999999999999997 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.78000000000000003 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.23999999999999999 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.12 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 0.37 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.92000000000000004 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 43' ' ' HIS . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.60999999999999999 112.544 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.56000000000000005 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.23999999999999999 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.05 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.17000000000000001 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.40999999999999998 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 0.84999999999999998 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 0.34999999999999998 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.54000000000000004 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.080000000000000002 112.528 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.17999999999999999 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 0.59999999999999998 111.031 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.77000000000000002 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.2 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.28999999999999998 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.48999999999999999 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 0.88 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.25 112.153 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.20999999999999999 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 19' ' ' VAL . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 110.022 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26000000000000001 110.796 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.070000000000000007 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.29999999999999999 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.32000000000000001 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.20000000000000001 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.33000000000000002 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.04 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.6100000000000001 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.47999999999999998 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65000000000000002 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 0.89000000000000001 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.0800000000000001 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 0.81000000000000005 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.4299999999999999 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.813 -0.44 . . . . 0.25 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.2 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.27 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.15 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.09 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.14 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.1 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.15 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.14 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.09 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.17 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.66 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.29 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.17 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 1.21 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.36 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.08 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.93 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.14 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 33' ' ' THR . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.28 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.23 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.2 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.22 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 1.06 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.33 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.43 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.19 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 0.72 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 23' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.25 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.5 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.26 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.38 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.46 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.2 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.18 111.065 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 19' ' ' VAL . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.21 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.3 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.36 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.26 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.47 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.49 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.71 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.125 -0.324 . . . . 0.25 110.125 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.2 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 0.27 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.15 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.09 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.14 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.1 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.15 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.14 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.09 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.17 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.66 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.29 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.17 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 1.21 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.36 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.08 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.93 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.14 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 33' ' ' THR . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.28 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.23 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.2 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.22 110.859 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 1.06 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.33 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.18 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.43 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.19 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 0.72 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 23' ' ' LEU . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.25 111.724 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.5 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.26 110.832 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.38 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.46 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.2 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.18 111.293 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.16 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.21 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.3 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.36 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.26 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.47 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.49 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HG2' HG22 ' A' ' 4' ' ' VAL . 3.3 pm0 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.144 -0.317 . . . . 0.31 110.144 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.67 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 2' ' ' GLN . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 0.6 111.691 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.36 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.36 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.97 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.45 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.2 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 0.44 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.24 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.67 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.15 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 0.45 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.47 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.44 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.42 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.48 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.25 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.12 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 0.2 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.25 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.35 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 1.55 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.24 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 0.39 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 0.94 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 0.65 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.81 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.02 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.14 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 0.71 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.4 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 0.3 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.38 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 1.92 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.5 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.48 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.47 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.2 112.603 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 1.48 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.89 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 0.94 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.231 0.104 0 N-CA-C 110.38 -0.23 . . . . 0.54 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.44 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.43 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.37 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.35 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.17 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.12 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.58 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.24 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.22 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.49 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.33 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.29 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.58 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 0.32 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.1 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.2 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.99 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.37 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.73 111.606 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.24 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.67 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.555 ' SG ' HG23 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 0.84 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.54 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.74 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.18 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.48 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.555 HG23 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 0.77 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.56 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 0.93 111.991 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.47 112.049 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.39 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.27 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.45 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.28 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.43 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.71 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.28 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.76 112.759 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.21 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.25 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.71 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.68 0.276 . . . . 1.0 111.032 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 6' ' ' ILE . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.696 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.15 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.24 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 0.25 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.22 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.92 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.19 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.76 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.32 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.16 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' HD12 ' A' ' 16' ' ' LEU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.27 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.33 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.4 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.68 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.72 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.66 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.32 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.43 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.596 ' HB3' HD23 ' A' ' 26' ' ' LEU . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.62 111.4 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.28 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.33 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 22' ' ' LEU . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.37 112.573 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.3 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.24 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.22 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.08 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.37 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.62 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.28 110.859 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.82 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.39 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 0.72 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 0.97 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.76 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 0.53 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.4 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.85 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.3 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.09 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.13 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.21 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 0.94 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.93 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 50' ' ' LEU . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 0.72 110.492 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.457 -0.572 . . . . 0.45 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.41 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.51 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.16 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 1.38 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.3 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 0.39 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.17 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.06 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 0.66 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 1.99 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.5 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 1.71 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.13 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.2 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.13 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.38 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.12 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 0.35 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.36 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.18 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.42 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.39 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.7 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.32 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 1.8 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.8 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.09 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.53 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.57 111.602 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.64 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.98 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.33 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.22 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 HG11 ' A' ' 19' ' ' VAL . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 0.4 110.789 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.39 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.52 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.06 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.38 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.49 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 1.98 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.59 111.121 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.28 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.02 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.67 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.588 -0.153 . . . . 1.06 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.81 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.59 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.2 111.037 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.36 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.26 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.58 110.432 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.37 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 0.81 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 0.84 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.23 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 0.81 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.35 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.13 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 40' ' ' ILE . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 0.31 110.875 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.36 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.23 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD12 HG21 ' A' ' 33' ' ' THR . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.39 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.24 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.28 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.33 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.31 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.38 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.56 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.23 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.4 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 23' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 0.32 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.546 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 0.57 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.72 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.08 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.12 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.19 111.566 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 19' ' ' VAL . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.26 110.538 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 1.45 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.31 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.21 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.43 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 1.86 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.33 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.655 0.264 . . . . 1.45 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.32 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.18 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.28 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.19 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.27 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.22 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.26 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 0.91 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.3 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.66 112.385 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.66 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.36 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.77 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 15' ' ' ALA . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.34 111.582 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 0.77 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.71 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 0.13 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.45 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.4 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 0.27 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.78 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.61 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.79 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.15 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 1.19 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.6 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 0.69 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.17 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.36 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.32 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 1.55 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91 112.532 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.79 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.53 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 0.4 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.2 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.07 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 0.99 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.27 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.24 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.16 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 1.66 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.78 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.56 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 8.1 pt20 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.246 -0.279 . . . . 0.62 110.246 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.37 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.49 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.15 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 2' ' ' GLN . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.32 111.302 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.32 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.66 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.23 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.15 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.36 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.65 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.18 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.97 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 1.39 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.47 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.35 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.41 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.51 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.41 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.26 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.32 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.25 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.16 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.11 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.31 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.5 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 1.47 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.18 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 0.22 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.15 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.86 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.1 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.43 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.19 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 19' ' ' VAL . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 0.31 110.154 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.21 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 1.43 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.41 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.35 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.66 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 1.82 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.18 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.29 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.4 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 109.997 -0.371 . . . . 0.75 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 0.2 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.429 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.49 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.16 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.36 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.48 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.8 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.13 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.18 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 0.34 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.09 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 0.18 110.612 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.38 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.3 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.429 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.34 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.29 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.81 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.24 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.23 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.36 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.16 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.27 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.23 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.59 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.39 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.02 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 1.39 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.694 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.04 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 0.71 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.32 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.12 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.16 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 0.2 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.19 111.013 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.34 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.12 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.5 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.702 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.61 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.72 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.41 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.27 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 1.71 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 0.84 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.29 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.99 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 47' ' ' LYS . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.44 111.326 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.662 0.268 . . . . 1.0 110.361 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.29 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.1 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.51 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.36 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.53 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.42 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.48 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 0.99 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.26 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 0.64 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.51 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.22 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.9 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.19 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.26 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 17' ' ' GLU . 13.2 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.29 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.49 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.45 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 0.49 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.43 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 0.36 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 1.08 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.41 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.2 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 1.41 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 0.46 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 0.27 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.24 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.13 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.14 111.146 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.23 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.23 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.2 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.53 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.81 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 0.78 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.65 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.47 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 110.062 -0.348 . . . . 1.52 110.062 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.41 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 21' ' ' ARG . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.43 110.728 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.16 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.23 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.23 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.24 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 1.78 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.42 110.153 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.58 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.56 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23 111.117 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.18 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.13 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.3 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.47 111.582 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.42 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.436 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.37 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.1 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.05 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 0.25 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.77 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.56 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.28 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.18 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.29 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.82 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 0.57 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.36 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.14 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.16 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 0.77 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.35 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.21 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.31 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 1.61 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.63 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.53 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.46 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.69 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.508 -0.553 . . . . 1.52 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.41 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.43 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.16 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.23 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.23 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.24 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 1.78 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.29 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.42 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.58 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.56 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.18 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.13 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.3 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.47 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.42 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.37 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.1 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.05 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 0.25 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.77 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.56 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.28 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.18 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' O ' HG12 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.29 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.82 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.57 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.36 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.14 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.16 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 0.77 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.35 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.21 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.31 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 1.61 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.63 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.53 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.46 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.69 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.619 0.247 . . . . 0.6 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 0.51 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 0.43 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.49 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.59 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.26 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.31 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.34 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.58 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 0.89 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.43 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.26 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.35 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.15 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.58 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.18 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.11 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.03 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.26 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.35 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.21 111.644 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.24 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.34 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.35 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.63 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 0.69 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.62 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.26 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.36 110.931 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.49 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.43 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.29 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.14 111.502 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.07 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.06 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.42 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.51 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 1.44 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 0.64 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 0.53 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.33 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.598 0.237 . . . . 0.85 110.996 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 0.49 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.25 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.36 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.15 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.14 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.28 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.32 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.22 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.39 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.36 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 1.7 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.29 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.45 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.61 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.94 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.75 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.36 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.17 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.48 111.491 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.99 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.59 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.85 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 1.48 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 35' ' ' GLU . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 0.76 110.901 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 0.55 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 33' ' ' THR . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.34 111.366 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.22 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.14 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.15 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.09 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.27 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.15 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.23 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.54 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.84 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.15 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 0.46 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.626 0.251 . . . . 0.67 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 4' ' ' VAL . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.57 111.986 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 3' ' ' VAL . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.65 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.59 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.18 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.35 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.28 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.24 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.17 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 16' ' ' LEU . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 0.5 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.3 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39 112.486 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 13' ' ' LYS . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.42 110.729 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 0.42 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 1.29 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 0.84 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.15 111.486 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HG ' HG11 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.35 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 0.78 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.35 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.38 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.32 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 0.51 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.76 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.47 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.04 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.36 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.0 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.6 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.19 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.32 110.593 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' THR . 4.4 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.52 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.6 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 0.64 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.26 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.19 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.31 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.95 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.83 110.828 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.22 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.36 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.03 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.48 109.987 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.32 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 110.02 -0.363 . . . . 1.9 110.02 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.41 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 0.65 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.26 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.27 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.2 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.35 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.71 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.29 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.3 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.65 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.55 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 0.88 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.36 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 1.23 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.27 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.97 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.58 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.1 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 0.7 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.36 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.16 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.42 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.72 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.32 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.65 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.08 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 0.65 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.2 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.13 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.4 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.24 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 0.27 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.18 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 19' ' ' VAL . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.27 110.221 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.12 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.7 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.24 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.25 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 0.99 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.2 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.43 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 6' ' ' ILE . 15.3 pm0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.165 -0.309 . . . . 1.9 110.165 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.41 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.65 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.26 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.27 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.2 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.35 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.71 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.29 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.3 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 0.65 110.684 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.55 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 13' ' ' LYS . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 0.88 111.735 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.36 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.23 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 40' ' ' ILE . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.27 111.351 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.97 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' HG12 ' A' ' 4' ' ' VAL . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.58 111.258 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.1 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 0.7 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.36 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.16 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.999 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.72 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.32 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.65 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.08 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 0.65 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.516 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.2 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.55 ' O ' HG12 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.13 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.4 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.24 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 0.27 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 0.18 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 HG11 ' A' ' 19' ' ' VAL . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.27 109.706 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.12 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.7 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.24 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.25 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 0.99 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.2 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.43 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.558 ' HG3' HG22 ' A' ' 4' ' ' VAL . 12.9 pt20 . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.441 -0.948 . . . . 0.68 108.441 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.22 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 2' ' ' GLN . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.9 111.369 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.17 111.369 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 0.36 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.39 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.73 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.87 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.35 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.15 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.24 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.5 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.1 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 0.59 112.626 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.26 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.15 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 0.72 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.27 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.02 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 0.53 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.33 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.17 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.18 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.11 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.13 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.64 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.65 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 0.45 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.4 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.22 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.608 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.47 110.885 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.47 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.24 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.46 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.43 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 19' ' ' VAL . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.69 110.937 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.798 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.58 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.31 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.93 110.893 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.51 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.42 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.16 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.2 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.09 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.05 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.09 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 0.78 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.24 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.12 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.61 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.56 111.8 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.24 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.05 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.17 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.41 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 0.35 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.54 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.08 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.18 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.6 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 0.77 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.29 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.49 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 0.88 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.25 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 38' ' ' VAL . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.21 112.149 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.26 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.07 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.3 112.77 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.32 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.31 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.2 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.33 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.04 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.61 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.48 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 0.89 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.08 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 0.81 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.43 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 N--CA 1.457 -0.087 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.16 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.2 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.09 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.05 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.09 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.78 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.24 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.12 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 0.37 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.92 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 43' ' ' HIS . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.61 112.544 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.56 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.05 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.17 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.41 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 0.85 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 0.35 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.54 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.08 112.528 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.18 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 0.6 111.031 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.77 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.2 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.29 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.49 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 0.88 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.5 HG23 HE21 ' A' ' 36' ' ' GLN . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.25 112.153 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.21 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 19' ' ' VAL . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.26 110.022 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.5 HE21 HG23 ' A' ' 33' ' ' THR . 9.7 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26 110.796 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.07 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.3 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.32 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.2 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.33 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.04 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.61 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.48 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 0.89 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.08 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 0.81 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.43 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.039 -0.356 . . . . 1.83 110.039 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -154.74 159.4 40.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.813 -0.44 . . . . 0.25 109.813 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.24 -31.73 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.062 0.393 . . . . 0.2 112.062 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.56 -13.32 15.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.27 111.43 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.84 -33.33 8.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.15 111.124 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.6 mt -70.76 -46.24 69.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.539 -0.3 . . . . 0.09 110.652 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.21 93.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.14 110.807 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.6 p -71.14 -23.55 62.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.984 -0.553 . . . . 0.17 111.188 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -73.72 -29.94 62.55 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.244 -0.65 . . . . 0.1 109.244 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.1 mm -83.9 -46.84 18.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.335 -0.848 . . . . 0.15 110.336 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.14 -39.63 57.79 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.922 -0.656 . . . . 0.14 112.766 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.79 1.48 61.72 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.9 -0.667 . . . . 0.09 112.687 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -125.97 89.21 2.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.646 -0.501 . . . . 0.17 109.646 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 50.8 tt0 -54.18 -47.63 71.81 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.627 0.603 . . . . 0.66 112.627 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -30.6 71.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.769 0.655 . . . . 0.62 112.769 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -87.97 -38.85 15.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.829 0.347 . . . . 1.29 111.539 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -33.66 68.83 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.844 0.354 . . . . 0.17 110.958 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -70.56 -33.56 71.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.031 -0.268 . . . . 1.21 111.535 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.8 p -72.44 -30.39 34.5 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.916 -0.314 . . . . 0.36 110.988 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -80.43 -24.3 39.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 2.08 110.406 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -86.85 -40.49 14.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.92 -0.582 . . . . 0.93 111.131 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 74.5 mt -85.54 -3.04 58.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.478 -0.328 . . . . 0.14 111.377 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 33' ' ' THR . 11.6 tp -55.85 -59.22 12.18 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.213 -0.449 . . . . 0.28 111.471 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -64.85 -31.27 57.53 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.646 1.564 . . . . 0.23 112.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.25 -58.3 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.055 -0.52 . . . . 0.2 111.297 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 4.0 mm? -70.44 -23.54 62.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.4 . . . . 0.22 111.234 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.8 t -76.26 -32.6 58.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 1.06 110.613 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -83.67 -40.95 18.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.658 0.266 . . . . 1.33 110.76 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.86 -36.05 72.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.636 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -129.05 -60.25 1.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.38 . . . . 0.43 111.193 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.2 -39.45 2.38 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.19 112.274 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.2 tp -60.35 -38.61 84.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.77 0.319 . . . . 0.72 110.795 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.523 HG21 HD12 ' A' ' 23' ' ' LEU . 3.7 m 59.91 74.04 0.6 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.784 -0.644 . . . . 0.25 110.916 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' O ' HG12 ' A' ' 38' ' ' VAL . 19.8 Cg_exo -65.41 -18.45 60.09 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.926 2.417 . . . . 0.5 112.406 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -57.48 -40.12 77.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.289 -0.414 . . . . 0.26 111.458 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 0.69 18.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.086 0.469 . . . . 0.38 110.671 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.1 t -112.59 -53.86 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.004 -0.543 . . . . 0.46 110.749 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -79.7 -53.45 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.589 0.589 . . . . 0.2 112.589 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -61.33 -44.73 96.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.951 0.405 . . . . 0.18 111.065 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.444 HD11 HG11 ' A' ' 19' ' ' VAL . 29.5 mm -61.19 -45.62 98.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.59 72.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.21 111.437 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 m -65.35 -29.51 70.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.769 0.319 . . . . 0.3 110.904 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -93.79 -47.68 6.65 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.568 -0.287 . . . . 0.36 110.688 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.63 -58.0 5.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.727 0.299 . . . . 1.21 111.121 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.95 45.18 1.98 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.765 -0.731 . . . . 0.26 111.995 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.85 -88.26 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.8 -0.714 . . . . 0.44 112.231 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -84.97 61.77 7.07 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.079 0.466 . . . . 1.47 111.437 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -109.95 -55.44 2.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.245 -0.65 . . . . 0.49 109.245 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.52 -11.87 61.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.623 . . . . 0.52 110.471 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.04 22.1 15.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.698 -0.683 . . . . 0.71 109.82 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.959 -0.544 . . . . 1.3 110.034 -179.633 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.774 0.321 . . . . 1.83 110.508 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -74.82 158.68 33.03 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.125 -0.324 . . . . 0.25 110.125 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 m -54.01 -32.74 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.571 0.582 . . . . 0.2 112.571 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.71 -28.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.644 0.259 . . . . 0.27 111.237 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.78 18.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.15 110.688 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.2 mt -67.86 -46.45 82.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.883 0.373 . . . . 0.09 110.311 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.43 99.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.118 -0.492 . . . . 0.14 111.212 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -69.47 -26.45 64.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.474 -0.33 . . . . 0.17 111.038 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.02 -32.16 70.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.235 0.541 . . . . 0.1 110.116 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 mm -83.75 -43.36 17.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.668 -0.696 . . . . 0.15 110.267 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.38 -43.04 55.33 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.838 -0.619 . . . . 0.14 112.719 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.7 -2.76 62.53 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.897 -0.668 . . . . 0.09 112.859 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -125.49 90.11 3.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.032 0.444 . . . . 0.17 110.139 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -51.4 -49.63 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.979 0.733 . . . . 0.66 112.979 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.0 9.76 3.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.275 0.843 . . . . 0.62 113.275 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.604 ' O ' HG12 ' A' ' 19' ' ' VAL . 18.4 mt -124.56 -39.1 2.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.927 0.394 . . . . 1.29 110.87 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.74 -39.74 61.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.283 0.563 . . . . 0.17 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.5 m -65.68 -38.15 88.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.571 -0.74 . . . . 1.21 111.266 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 16' ' ' LEU . 2.1 p -63.14 -28.27 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.444 -0.343 . . . . 0.36 111.758 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -88.13 -23.82 23.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 2.08 110.827 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -82.09 -37.81 25.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.484 -0.325 . . . . 0.93 110.559 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.3 mt -85.03 -15.74 43.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.418 -0.356 . . . . 0.14 110.792 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 HG21 ' A' ' 33' ' ' THR . 4.3 tp -52.22 -59.51 8.27 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.031 -0.531 . . . . 0.28 111.895 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 27.1 Cg_endo -61.47 -33.15 88.59 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.068 1.845 . . . . 0.23 112.385 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 t -65.59 -48.38 82.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.2 110.543 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.8 mm? -68.18 -29.92 68.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.011 -0.54 . . . . 0.22 110.859 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.5 m -71.86 -42.11 67.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.943 0.402 . . . . 1.06 109.997 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -71.25 -40.23 71.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.893 -0.594 . . . . 1.33 111.646 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.02 -29.17 35.18 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.261 0.467 . . . . 0.18 112.261 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -134.38 -83.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.336 . . . . 0.43 111.386 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.09 -35.59 1.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.296 -0.954 . . . . 0.19 113.171 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 tp -67.29 -39.91 86.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.911 0.355 . . . . 0.72 110.714 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 23' ' ' LEU . 1.6 m 64.23 83.27 0.2 Allowed Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.705 -0.679 . . . . 0.25 111.724 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 38' ' ' VAL . 60.3 Cg_endo -72.72 -11.09 25.75 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.481 2.121 . . . . 0.5 112.369 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.9 mm-40 -58.6 -41.35 85.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.999 0.428 . . . . 0.26 110.832 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -81.08 6.91 12.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.38 110.653 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.04 -43.53 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.46 110.747 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 34' ' ' PRO . 6.6 p -99.99 -47.0 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 112.449 0.537 . . . . 0.2 112.449 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -62.2 -51.36 68.11 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.96 0.41 . . . . 0.18 111.293 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.09 -44.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.95 -0.568 . . . . 0.16 110.183 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.08 81.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.038 -0.528 . . . . 0.21 111.595 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 m -65.92 -38.05 87.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.813 0.339 . . . . 0.3 111.317 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 78.2 t60 -81.99 -41.83 20.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.631 0.253 . . . . 0.36 111.35 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -72.63 -51.7 18.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.398 -0.365 . . . . 1.21 111.796 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.8 70.57 0.21 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.647 -0.787 . . . . 0.26 112.339 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 -50.18 0.37 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.922 -0.656 . . . . 0.44 112.423 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 19.1 mttt -107.09 29.85 6.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.012 0.434 . . . . 1.47 110.825 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -76.64 -44.27 34.76 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.576 -0.527 . . . . 0.49 109.576 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.01 7.84 26.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.61 -0.723 . . . . 0.52 110.499 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -120.69 18.27 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.189 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.195 -0.907 . . . . 1.3 109.501 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.807 0.337 . . . . 1.19 110.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.556 ' HG2' HG22 ' A' ' 4' ' ' VAL . 3.3 pm0 -89.84 177.95 6.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.854 -0.612 . . . . 0.31 110.144 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 m -54.68 -38.57 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.612 0.597 . . . . 0.67 112.612 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 2' ' ' GLN . 10.2 m -70.94 -11.17 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.655 0.264 . . . . 0.6 111.691 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.44 -37.33 10.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.821 0.343 . . . . 0.36 110.141 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.2 mt -60.72 -48.9 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.48 110.496 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.09 79.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.36 110.922 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -67.94 -34.43 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 0.26 110.766 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -73.69 -40.46 63.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.207 -0.451 . . . . 0.97 110.596 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.1 mm -68.93 -42.04 82.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.45 110.493 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.25 -7.38 88.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.845 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.99 -29.8 3.74 Favored Glycine 0 CA--C 1.517 0.163 0 C-N-CA 121.155 -0.545 . . . . 0.2 112.617 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -74.92 67.82 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.847 0.459 . . . . 0.44 111.168 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -50.15 -55.26 15.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.06 -0.518 . . . . 1.45 112.031 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' HIS . . . -106.01 31.52 5.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.95 0.405 . . . . 1.24 111.547 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 19' ' ' VAL . 6.6 mt -132.73 -35.2 1.11 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.298 -0.41 . . . . 0.67 111.067 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.4 -44.55 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.394 0.616 . . . . 1.15 109.697 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.88 -27.53 68.92 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.323 -0.853 . . . . 0.45 111.496 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 16' ' ' LEU . 3.5 p -75.15 -18.18 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.47 111.121 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -93.68 -30.42 14.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.862 0.363 . . . . 0.44 110.264 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -79.34 -39.7 32.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.161 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -79.17 -17.56 54.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.593 -0.276 . . . . 0.42 110.96 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 tp -53.38 -60.11 7.74 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 115.858 -0.61 . . . . 0.48 112.427 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.07 -30.21 88.94 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 121.933 1.755 . . . . 0.25 112.492 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.81 -52.54 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.082 0.468 . . . . 0.12 110.558 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.29 -31.11 67.07 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.993 -0.549 . . . . 0.2 111.233 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 69.7 m -72.86 -35.85 67.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.566 -0.288 . . . . 1.25 111.434 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -75.24 -30.8 60.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.221 0.534 . . . . 0.35 109.936 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.54 -57.99 3.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.736 -0.665 . . . . 0.64 111.532 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -114.6 -49.11 2.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.867 0.321 . . . . 1.55 111.867 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 86.69 25.58 34.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.219 -0.991 . . . . 0.24 112.351 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.4 1.62 27.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.544 0.211 . . . . 0.39 111.272 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 p 45.46 68.53 3.24 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.842 -0.617 . . . . 0.94 111.953 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.8 -21.67 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.999 2.466 . . . . 0.65 112.336 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -68.31 -39.54 82.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.048 -0.524 . . . . 0.57 110.81 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -70.46 -25.26 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.653 0.264 . . . . 1.02 111.424 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.8 t -78.91 -16.76 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.747 0.308 . . . . 1.14 111.516 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.83 -46.39 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 0.71 112.244 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.38 -54.15 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.603 0.223 . . . . 0.4 111.603 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 35.5 mm -60.19 -45.99 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.766 0.317 . . . . 0.3 110.565 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.2 92.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.981 -0.554 . . . . 0.38 111.672 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 m -70.54 -26.32 63.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.659 0.266 . . . . 0.33 111.587 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 62.3 t60 -81.61 -50.42 9.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.912 0.387 . . . . 1.92 110.545 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.65 -57.33 5.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.639 -0.71 . . . . 0.5 111.617 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -100.75 44.3 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.502 -0.856 . . . . 0.48 112.418 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.38 -61.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.287 -0.959 . . . . 0.47 113.378 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 1.7 mmtp -62.66 -15.94 54.57 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.603 0.594 . . . . 1.2 112.603 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -63.41 -19.1 64.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 1.48 110.814 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.04 -1.9 58.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.89 110.645 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.67 -47.64 2.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.057 -0.52 . . . . 0.94 110.598 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.781 -0.628 . . . . 1.78 110.51 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.347 -0.242 . . . . 1.1 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.99 152.76 44.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.42 -0.355 . . . . 0.54 110.38 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -53.23 -31.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.157 0.429 . . . . 0.44 112.157 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.6 m -68.36 -24.16 29.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.689 0.28 . . . . 0.43 111.081 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -96.84 -21.77 17.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.053 0.454 . . . . 0.37 110.529 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 81.4 mt -75.22 -50.9 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.25 110.125 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.83 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.841 -0.618 . . . . 0.35 111.119 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 3.8 p -70.62 -35.91 73.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.488 -0.323 . . . . 0.17 111.355 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 21.7 t30 -64.25 -37.83 88.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.002 0.429 . . . . 1.12 110.522 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -81.11 -48.91 18.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.816 -0.629 . . . . 0.58 110.828 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.6 -25.86 71.73 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.198 -0.525 . . . . 0.24 113.445 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.29 -20.62 32.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.063 -0.589 . . . . 0.22 111.868 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -85.37 77.96 9.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.49 110.329 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 54.3 mt-30 -76.54 53.61 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.267 0.556 . . . . 1.79 111.332 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.81 -51.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.145 -0.934 . . . . 1.33 109.497 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.4 mt -78.11 -38.11 44.77 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.756 -0.656 . . . . 1.29 111.293 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -71.18 -39.61 71.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.394 -0.366 . . . . 0.58 111.298 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 t -70.41 -40.89 73.59 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.042 -0.263 . . . . 0.32 111.018 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.14 -27.84 38.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 CA-C-O 120.843 0.354 . . . . 1.1 110.485 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.94 -24.13 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.052 0.453 . . . . 1.2 110.432 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -93.89 -28.32 15.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.897 -0.592 . . . . 0.99 110.687 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.8 -19.82 31.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.377 -0.374 . . . . 0.37 111.174 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 24' ' ' PRO . 10.4 tp -54.63 -55.4 38.3 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.056 -0.52 . . . . 0.73 111.606 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 41.6 Cg_endo -66.94 -2.53 7.99 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.938 1.759 . . . . 0.34 112.949 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -98.74 -57.21 4.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.159 0.504 . . . . 0.24 110.127 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.47 -37.25 82.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.909 -0.587 . . . . 0.67 110.906 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.555 ' SG ' HG23 ' A' ' 33' ' ' THR . 89.8 m -74.67 -12.08 60.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.307 -0.406 . . . . 0.84 111.071 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 12.5 tp60 -92.29 -39.8 11.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.947 -0.39 . . . . 1.54 109.947 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.77 -39.2 44.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.1 -0.5 . . . . 0.74 111.507 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.82 -54.13 2.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 1.18 111.372 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.423 -0.894 . . . . 0.33 112.59 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.06 3.89 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.48 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.555 HG23 ' SG ' ' A' ' 27' ' ' CYS . 0.0 OUTLIER 49.18 58.13 17.97 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.719 -0.673 . . . . 0.77 111.772 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -86.07 2.16 7.57 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.359 2.04 . . . . 0.56 112.725 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -89.11 -58.07 2.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.096 0.474 . . . . 1.51 110.276 -179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.97 -33.3 68.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.688 -0.687 . . . . 0.93 111.991 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.78 -37.88 68.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.049 0.388 . . . . 0.47 112.049 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.28 -39.41 6.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.158 0.429 . . . . 0.39 112.158 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.97 77.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.211 0.448 . . . . 0.27 112.211 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.02 -42.28 82.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.67 0.271 . . . . 0.45 110.576 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.71 88.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.28 111.392 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -71.28 -11.9 61.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.692 0.282 . . . . 0.17 111.371 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -96.32 -61.39 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.194 -0.299 . . . . 0.43 110.194 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 38.6 t70 -70.08 -29.11 66.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 1.74 112.099 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.28 19.7 14.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.073 -1.061 . . . . 0.71 112.518 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.13 -76.02 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.124 -1.036 . . . . 0.28 113.303 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.86 12.53 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.759 0.652 . . . . 0.76 112.759 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 3.3 mm-40 -65.15 -38.08 89.45 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.486 -0.561 . . . . 1.21 109.486 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.31 -21.74 55.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.668 -0.696 . . . . 0.25 110.168 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.74 29.4 6.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.23 0.538 . . . . 0.71 109.847 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.142 -0.932 . . . . 1.45 109.586 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 121.065 0.459 . . . . 2.32 109.845 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -73.67 157.14 37.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.032 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.403 ' HA ' HG12 ' A' ' 6' ' ' ILE . 5.0 m -59.44 -28.83 40.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.258 -0.428 . . . . 0.51 111.696 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.0 m -78.47 -13.53 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.15 111.282 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.08 -41.08 6.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.753 0.311 . . . . 0.24 111.744 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 10' ' ' ILE . 24.7 pt -67.86 -37.6 78.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.885 -0.326 . . . . 0.25 111.197 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' N ' HG13 ' A' ' 6' ' ' ILE . . . -69.41 -41.31 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.968 0.414 . . . . 0.22 110.915 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 4.4 p -71.15 -30.38 66.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 0.92 111.182 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -24.2 65.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.985 0.422 . . . . 1.19 110.652 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 6' ' ' ILE . 27.9 mm -93.02 -36.04 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.126 -0.488 . . . . 0.76 109.921 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.22 -35.9 36.6 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.016 -0.611 . . . . 0.32 112.709 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.43 6.46 62.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.12 -0.562 . . . . 0.16 112.501 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' HD12 ' A' ' 16' ' ' LEU . 21.8 mtmm -133.38 94.66 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.821 0.343 . . . . 0.27 110.125 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 9.7 mp0 -61.45 -50.78 71.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.644 0.609 . . . . 1.33 112.644 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.72 63.44 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.49 0.552 . . . . 0.4 112.49 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.541 HD12 ' HD2' ' A' ' 13' ' ' LYS . 92.7 mt -87.8 -18.25 29.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 111.85 0.315 . . . . 0.68 111.85 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -90.65 -34.33 15.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.673 0.273 . . . . 0.55 110.683 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.5 t -64.3 -34.31 77.83 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.642 -0.254 . . . . 0.72 111.248 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 9.4 p -65.75 -27.33 41.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-O 120.646 0.26 . . . . 0.66 111.275 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.98 -27.34 16.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.951 0.405 . . . . 0.32 110.844 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -77.36 -46.29 23.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.147 -0.479 . . . . 1.43 110.939 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.596 ' HB3' HD23 ' A' ' 26' ' ' LEU . 50.7 mt -89.04 -0.01 57.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.199 -0.455 . . . . 0.62 111.4 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 46.9 tp -56.81 -60.57 9.02 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.321 -0.4 . . . . 0.28 111.777 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.1 Cg_endo -60.68 -36.22 85.94 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.846 1.697 . . . . 0.45 112.371 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.1 t -65.48 -56.0 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.33 111.442 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 22' ' ' LEU . 4.2 mm? -68.59 -36.52 78.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.573 0.583 . . . . 0.37 112.573 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 15.1 p -68.51 -24.83 64.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.807 0.337 . . . . 0.3 111.413 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -91.93 -44.15 9.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.312 -0.404 . . . . 1.24 110.887 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.97 -36.51 77.97 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.467 0.543 . . . . 0.22 112.467 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -132.64 -43.67 0.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.832 -0.347 . . . . 1.08 111.674 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.65 -36.44 4.34 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.719 -0.753 . . . . 0.37 112.117 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 mt -55.62 -51.77 66.04 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 122.626 0.371 . . . . 0.62 111.407 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 5.9 m 65.71 80.62 0.23 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.987 -0.552 . . . . 0.28 110.859 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.26 -13.66 40.29 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.851 2.367 . . . . 0.82 112.996 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 29.4 mm-40 -60.46 -41.05 93.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.972 0.415 . . . . 1.39 110.859 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.51 -4.91 58.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.911 0.386 . . . . 0.72 110.837 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.93 -54.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.229 -0.442 . . . . 0.97 112.181 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 p -111.99 -36.23 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 113.312 0.856 . . . . 0.76 113.312 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -59.91 -56.4 22.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 117.969 0.349 . . . . 0.5 110.884 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.9 mm -63.51 -36.74 77.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.197 -0.456 . . . . 0.53 110.117 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.1 84.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.879 -0.601 . . . . 0.4 111.658 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 m -64.73 -37.37 87.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.886 0.374 . . . . 0.85 110.738 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 46.0 t60 -78.06 -41.18 36.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.3 110.03 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.71 -63.68 1.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.842 -0.617 . . . . 1.09 111.307 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.28 80.67 0.28 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.999 -0.619 . . . . 0.13 112.487 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.04 -71.53 0.27 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.455 -0.879 . . . . 0.21 112.735 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 27.9 tptt -72.3 -18.65 61.77 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.735 0.272 . . . . 0.94 111.735 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.91 -19.59 66.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 1.93 111.038 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.19 -2.03 56.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.06 0.457 . . . . 0.39 110.358 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 50' ' ' LEU . 4.0 mm? -112.64 -35.37 5.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.886 -0.597 . . . . 0.72 110.492 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG3' ' HG3' ' A' ' 47' ' ' LYS . 41.2 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.494 -0.765 . . . . 1.27 110.534 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.975 0.417 . . . . 1.38 110.558 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -117.53 159.2 23.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.457 -0.572 . . . . 0.45 109.457 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.4 m -55.51 -32.92 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.038 0.384 . . . . 0.41 112.038 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.498 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 26.7 m -74.91 -1.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.029 0.442 . . . . 0.51 111.347 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.73 7.46 14.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.359 0.6 . . . . 1.16 109.654 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 10' ' ' ILE . 63.4 mt -118.38 -61.98 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.284 -0.871 . . . . 1.38 109.993 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.55 -51.1 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.3 110.636 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' A' ' 17' ' ' GLU . 1.1 m -60.59 -33.4 72.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.553 -0.748 . . . . 0.39 111.065 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -66.15 -47.79 72.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.943 -0.571 . . . . 0.92 111.127 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 6' ' ' ILE . 25.1 mm -71.21 -25.0 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.011 0.434 . . . . 0.17 110.745 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.21 -9.27 87.11 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.749 -0.739 . . . . 0.06 112.331 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.77 -50.71 4.45 Favored Glycine 0 N--CA 1.454 -0.148 0 N-CA-C 111.289 -0.724 . . . . 0.31 111.289 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -79.98 67.61 5.84 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.696 -0.483 . . . . 0.66 109.696 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -54.64 -56.9 14.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.696 -0.684 . . . . 1.99 112.151 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -23.77 65.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.822 0.675 . . . . 0.5 112.822 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 6.8 mp -87.18 -33.83 19.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.838 -0.345 . . . . 1.71 111.349 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB3' ' CB ' ' A' ' 8' ' ' SER . 5.1 tm-20 -80.98 -38.49 27.52 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.197 -0.298 . . . . 2.13 110.197 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.498 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 12.4 t -60.67 -34.36 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.606 -0.27 . . . . 0.2 110.738 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 40' ' ' ILE . 3.6 p -76.45 -26.65 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.13 109.993 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -74.18 -34.36 63.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.806 -0.634 . . . . 2.38 109.562 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -83.71 -31.81 25.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.824 -0.626 . . . . 1.12 111.64 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 mt -78.78 -27.1 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.817 -0.174 . . . . 0.35 111.41 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 tp -49.98 -57.49 12.37 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 -23.57 74.71 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.056 1.837 . . . . 0.36 113.003 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.59 -55.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.912 0.387 . . . . 0.18 110.857 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.76 -30.53 70.01 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.322 -0.399 . . . . 0.42 111.08 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 3.6 t -72.33 -19.76 61.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.813 0.339 . . . . 0.39 110.762 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -88.26 -44.97 10.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.7 110.895 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.26 -47.43 35.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.32 112.493 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -113.84 -50.72 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.834 -0.347 . . . . 1.8 111.935 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 90.22 -6.74 82.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.398 -0.906 . . . . 0.31 112.079 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.7 -8.79 59.74 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.885 -0.185 . . . . 0.8 111.255 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 p 46.07 74.51 0.79 Allowed Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 124.007 0.817 . . . . 1.09 112.363 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -87.31 -15.76 3.46 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.971 2.447 . . . . 0.53 112.635 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -64.78 -45.21 87.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.461 . . . . 1.57 111.602 -178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -68.75 -24.0 64.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.871 0.367 . . . . 1.64 110.913 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.97 -22.13 21.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.839 -0.619 . . . . 0.98 111.412 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.55 -46.16 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.686 0.624 . . . . 0.33 112.686 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.07 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.963 0.357 . . . . 0.22 111.963 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.503 HD11 HG11 ' A' ' 19' ' ' VAL . 41.9 mm -67.63 -42.48 86.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 0.4 110.789 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.75 -48.32 79.96 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.425 0.528 . . . . 0.39 112.425 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.4 m -68.22 -29.9 68.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.835 0.309 . . . . 0.46 111.835 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 4.6 t60 -82.13 -37.13 26.7 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.482 -0.487 . . . . 0.52 111.174 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -66.61 -61.09 2.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.363 -0.38 . . . . 1.06 110.727 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.17 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.72 -0.753 . . . . 0.38 112.279 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.29 -80.89 0.17 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.3 -0.952 . . . . 0.49 113.318 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 43.4 tptt -59.73 -25.99 65.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.428 0.529 . . . . 1.98 112.428 -178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -64.39 -19.64 65.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.7 0.286 . . . . 0.59 111.121 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.03 -9.36 58.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.046 0.45 . . . . 0.28 110.42 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.59 11.88 12.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.818 -0.628 . . . . 1.02 109.695 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.167 -0.92 . . . . 1.67 109.913 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.165 -0.309 . . . . 1.45 110.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.32 176.89 7.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 1.06 110.588 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 m -54.17 -37.79 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 112.676 0.621 . . . . 0.81 112.676 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.04 -21.19 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.807 0.337 . . . . 0.59 111.391 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 9' ' ' ASN . . . -82.64 -39.18 22.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.2 111.037 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.0 pt -66.84 -27.36 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.959 0.409 . . . . 0.36 110.569 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 -45.15 23.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.934 -0.576 . . . . 0.26 110.59 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 14' ' ' GLN . 12.8 p -72.65 -25.98 61.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.969 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 5' ' ' ALA . 10.4 t-20 -59.46 -40.98 88.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.23 -0.441 . . . . 0.58 110.432 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -66.24 -38.19 81.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.933 -0.576 . . . . 0.33 110.42 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.12 -21.51 78.03 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.706 -0.679 . . . . 0.37 111.993 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.9 7.61 80.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 121.199 -0.524 . . . . 0.52 112.424 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 79.6 1.91 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.117 0.484 . . . . 0.81 110.652 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 8' ' ' SER . 1.0 OUTLIER -64.29 -31.14 72.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.378 -0.828 . . . . 0.84 111.765 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.3 16.17 26.42 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.004 0.372 . . . . 0.23 112.004 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -44.07 1.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.276 . . . . 0.81 111.026 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 8' ' ' SER . 0.7 OUTLIER -77.45 -36.88 52.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.911 0.386 . . . . 1.35 110.507 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.1 m -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.032 -0.531 . . . . 1.13 112.171 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.422 HG21 HG12 ' A' ' 40' ' ' ILE . 7.3 p -61.71 -35.29 66.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.632 0.253 . . . . 0.31 110.875 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -75.92 -38.81 57.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.907 0.384 . . . . 1.36 110.33 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -67.47 -34.32 76.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.57 111.281 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 70.7 mt -90.36 -9.05 49.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.42 -0.355 . . . . 0.23 111.341 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD12 HG21 ' A' ' 33' ' ' THR . 4.7 tp -56.59 -58.14 19.07 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.425 -0.352 . . . . 0.39 111.685 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 23.8 Cg_endo -59.65 -34.41 96.43 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.062 1.841 . . . . 0.24 112.24 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.26 -52.76 51.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.727 -0.67 . . . . 0.28 110.344 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 2.4 mm? -68.99 -32.98 72.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.757 -0.656 . . . . 0.33 111.704 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.8 m -69.44 -33.16 72.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.86 0.362 . . . . 0.27 110.901 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -82.16 -44.6 16.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.294 -0.412 . . . . 1.31 111.626 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.64 -25.25 49.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.626 0.602 . . . . 0.38 112.626 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -133.45 -67.67 0.6 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.915 0.388 . . . . 0.56 111.751 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.47 -39.77 2.2 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.396 -0.681 . . . . 0.23 111.396 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.24 -48.16 81.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.4 110.74 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 23' ' ' LEU . 3.3 m 61.19 76.9 0.38 Allowed Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 115.688 -0.687 . . . . 0.32 111.006 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.546 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.0 Cg_exo -67.25 -11.07 30.82 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.831 2.354 . . . . 0.57 112.26 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -57.76 -37.23 73.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.019 0.438 . . . . 0.72 110.508 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.03 -20.42 59.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.286 0.565 . . . . 1.2 110.106 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.92 -31.85 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.406 -0.815 . . . . 0.08 111.963 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.3 p -107.58 -53.93 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 112.907 0.706 . . . . 0.12 112.907 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.401 ' N ' HG13 ' A' ' 38' ' ' VAL . . . -60.94 -54.88 39.56 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.068 0.395 . . . . 0.19 111.566 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.422 HG12 HG21 ' A' ' 19' ' ' VAL . 7.2 mm -60.26 -40.97 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.35 -0.386 . . . . 0.26 110.538 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.23 -41.85 93.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.13 111.175 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.2 m -66.41 -31.37 72.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.868 0.366 . . . . 0.27 110.392 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 32.9 t-80 -76.54 -51.72 11.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.488 -0.324 . . . . 1.45 110.477 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.6 -46.82 74.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.783 0.325 . . . . 0.28 111.832 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.8 59.2 0.39 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.531 -0.843 . . . . 0.27 112.645 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.8 -76.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.537 -0.84 . . . . 0.34 112.721 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -62.62 -25.5 68.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.765 0.283 . . . . 1.31 111.765 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.7 tp60 -62.24 -23.54 66.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.583 -0.28 . . . . 1.21 111.169 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.78 -12.33 53.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.879 0.371 . . . . 0.43 110.721 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -104.62 -20.0 13.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 1.86 111.071 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.496 -0.764 . . . . 1.33 110.579 179.803 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.464 0.173 . . . . 0.73 111.145 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.61 150.13 32.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.655 0.264 . . . . 1.45 110.564 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -56.91 -28.12 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.97 -0.559 . . . . 0.32 112.463 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -73.25 -11.23 14.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.66 111.26 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.9 -39.84 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.021 0.439 . . . . 0.18 110.239 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.99 -53.86 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.841 -0.618 . . . . 0.25 111.245 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.1 81.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.28 111.384 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 19.1 m -68.55 -38.41 80.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.011 -0.541 . . . . 0.19 111.098 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -63.61 -48.35 77.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.322 -0.399 . . . . 0.27 110.413 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.25 -34.75 64.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.133 -0.485 . . . . 1.22 110.693 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.01 -27.58 72.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.898 -0.668 . . . . 0.26 112.34 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.47 -45.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.079 -0.582 . . . . 0.26 111.841 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 26.4 mtmm -86.49 71.86 10.36 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.653 -0.499 . . . . 0.91 109.653 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 42.8 tt0 -45.16 -49.17 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.55 -0.75 . . . . 1.3 112.67 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -72.29 -51.97 18.41 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.385 0.513 . . . . 1.66 112.385 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -46.85 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.314 0.487 . . . . 0.66 112.314 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -59.48 -40.83 88.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.995 0.426 . . . . 1.36 110.115 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -62.0 -45.09 95.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.674 -0.694 . . . . 0.77 110.617 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 15' ' ' ALA . 93.6 t -64.76 -46.98 90.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.34 111.582 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -67.46 -12.99 61.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.931 0.345 . . . . 0.77 111.931 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -100.92 -34.7 9.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.613 -0.267 . . . . 0.71 111.039 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.1 mt -86.42 -34.88 20.01 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.374 0.509 . . . . 0.13 112.374 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.475 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 42.9 tp -52.0 -53.98 45.79 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.005 0.372 . . . . 0.45 112.005 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 13.3 Cg_endo -57.04 -19.73 34.15 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.337 2.025 . . . . 0.4 113.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -93.15 -52.71 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.991 0.424 . . . . 0.27 110.657 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.34 -31.87 73.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.78 111.602 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 35.8 t -63.83 -27.13 68.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.326 -0.397 . . . . 0.61 110.523 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -93.28 -42.63 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.209 -0.45 . . . . 0.79 110.643 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.48 -56.63 19.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.815 -0.63 . . . . 0.15 112.226 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -123.44 -32.78 3.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.803 0.335 . . . . 1.19 111.663 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 70.83 39.61 65.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.664 -0.779 . . . . 0.6 112.887 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.63 6.16 11.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.73 0.265 . . . . 0.69 111.154 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t 34.85 69.28 1.07 Allowed Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 124.192 0.933 . . . . 1.17 112.727 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -96.43 21.49 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.286 2.657 . . . . 1.36 112.441 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 -40.22 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.987 0.422 . . . . 1.32 110.81 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -68.62 -41.79 79.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.246 -0.433 . . . . 1.55 111.182 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.4 t -73.7 -1.17 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.532 0.567 . . . . 0.91 112.532 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.17 -52.19 3.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 121.693 -0.63 . . . . 0.79 111.739 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.25 -44.22 76.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.76 0.314 . . . . 0.53 111.768 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.36 -43.65 80.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.869 -0.332 . . . . 0.4 110.477 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.34 -48.13 83.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.035 -0.529 . . . . 0.2 112.085 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.6 m -70.42 -30.15 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.132 0.419 . . . . 1.07 112.132 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -80.38 -47.82 13.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.062 -0.399 . . . . 0.99 111.105 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -70.57 -39.35 73.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.187 -0.46 . . . . 0.27 111.073 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.18 57.53 0.53 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.758 . . . . 0.31 112.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.95 -73.69 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.936 -0.649 . . . . 0.24 112.159 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -2.28 11.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.876 0.369 . . . . 1.16 111.095 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -64.7 -41.28 96.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 1.66 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.49 -8.43 59.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.005 0.431 . . . . 0.78 110.771 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.88 30.04 7.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.979 -0.555 . . . . 0.56 109.879 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.244 0.813 0 CA-C-O 118.39 -0.814 . . . . 1.48 110.015 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.705 0.288 . . . . 0.77 110.475 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.406 ' O ' HG12 ' A' ' 6' ' ' ILE . 8.1 pt20 -104.08 -171.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.246 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 m -55.62 -36.24 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 112.284 0.476 . . . . 0.37 112.284 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.6 m -88.66 16.94 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.949 0.404 . . . . 0.49 111.413 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.75 -43.42 1.24 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.398 -0.365 . . . . 0.15 111.339 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 2' ' ' GLN . 20.3 pt -61.84 -47.57 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.728 0.299 . . . . 0.32 111.302 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.46 79.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.947 0.403 . . . . 0.32 110.218 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 3.8 m -62.41 -35.91 80.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.615 -0.72 . . . . 0.44 111.585 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -71.25 -33.05 69.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.163 0.506 . . . . 0.66 110.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.8 mm -77.79 -49.13 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.776 -0.647 . . . . 0.23 110.728 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.33 -43.79 94.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.76 -0.733 . . . . 0.15 112.194 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.04 -3.2 58.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.761 -0.733 . . . . 0.36 112.302 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -118.71 86.46 2.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.899 -0.408 . . . . 0.65 109.899 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.511 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 5.5 mt-30 -50.56 -57.86 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.156 0.798 . . . . 1.18 113.156 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.78 -22.72 66.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.342 0.867 . . . . 0.97 113.342 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 44.7 mt -92.67 -28.84 16.41 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.709 -0.396 . . . . 1.39 111.568 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.47 -34.82 47.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.88 0.371 . . . . 0.47 110.387 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -70.25 -36.54 74.54 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.338 -0.392 . . . . 0.35 111.382 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 14.9 p -68.15 -31.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.785 0.326 . . . . 0.41 110.902 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -81.74 -30.21 32.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.51 110.576 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . 2.8 tpm_? -77.58 -43.21 32.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.852 -0.613 . . . . 1.41 111.214 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 mt -87.42 -0.46 56.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.395 -0.366 . . . . 0.26 111.681 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 15.7 tp -58.86 -60.48 10.34 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.568 -0.287 . . . . 0.32 111.382 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -63.22 -21.8 72.31 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.973 1.782 . . . . 0.25 112.316 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.5 t -74.65 -59.11 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.108 -0.496 . . . . 0.16 110.807 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.91 -31.42 70.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.049 -0.523 . . . . 0.11 111.991 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 93.0 m -73.71 -22.95 59.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.56 0.219 . . . . 0.31 111.348 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -94.69 -42.81 8.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.65 0.262 . . . . 0.5 110.973 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.68 91.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.127 0.418 . . . . 0.13 112.127 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -132.22 -41.62 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.977 -0.289 . . . . 1.47 111.631 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 88.08 35.26 9.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.514 -0.85 . . . . 0.39 112.315 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.1 mt -120.35 -12.94 8.92 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.735 0.272 . . . . 0.18 111.735 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.552 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 11.8 t 36.23 69.31 1.24 Allowed Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 121.921 0.867 . . . . 0.22 113.04 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.66 -17.25 42.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.354 2.036 . . . . 0.15 112.162 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 13.4 mm-40 -62.61 -35.18 78.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.194 0.521 . . . . 0.86 110.246 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -80.34 2.11 26.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.163 0.506 . . . . 1.1 110.484 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.8 t -107.18 -51.6 7.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.835 -0.62 . . . . 0.43 110.754 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.39 -48.74 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.875 0.694 . . . . 0.19 112.875 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -60.16 -50.51 73.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.667 0.27 . . . . 0.13 111.458 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD11 HG11 ' A' ' 19' ' ' VAL . 29.6 mm -60.43 -42.24 90.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 110.154 -0.313 . . . . 0.31 110.154 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.31 93.65 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 116.011 -0.54 . . . . 0.21 111.048 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -63.95 -37.69 88.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.31 110.813 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -72.72 -40.63 65.99 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.686 0.279 . . . . 1.43 110.646 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.31 -59.55 2.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.73 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.25 106.76 1.85 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.41 -0.676 . . . . 0.41 111.41 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.3 -66.0 0.57 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.301 -0.72 . . . . 0.35 111.301 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 47' ' ' LYS . 10.0 tmtt? -64.18 -31.35 72.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 1.66 110.145 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.75 -35.42 80.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 1.82 110.473 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.45 -15.3 59.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.18 111.379 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -97.99 -35.84 10.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.29 110.911 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 115.666 -0.697 . . . . 2.4 110.818 -179.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.334 -0.247 . . . . 0.88 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -149.41 149.76 31.33 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.997 -0.371 . . . . 0.75 109.997 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.3 m -61.05 -31.63 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.732 0.301 . . . . 0.2 111.493 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 33.0 m -71.42 -4.32 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.783 0.325 . . . . 0.49 111.529 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.49 -43.07 2.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.583 -0.28 . . . . 0.16 110.361 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.18 -50.5 79.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.381 -0.372 . . . . 0.36 110.52 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.52 -41.17 89.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.486 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.1 m -70.71 -29.89 66.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.684 -0.689 . . . . 0.48 111.544 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -70.16 -41.81 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.8 110.312 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.52 -37.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.882 -0.599 . . . . 1.13 110.315 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.64 -25.86 74.78 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.854 -0.689 . . . . 0.17 112.301 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.52 -28.49 14.01 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.962 -0.637 . . . . 0.18 112.284 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.6 mttp -90.69 86.91 6.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.723 0.297 . . . . 0.34 110.405 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 3.6 pt20 -72.64 15.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.006 0.373 . . . . 1.09 112.006 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.42 -48.53 0.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.359 -0.382 . . . . 0.18 110.612 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 38.3 mt -74.9 -29.84 61.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.38 112.03 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -75.59 -34.89 60.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.016 0.436 . . . . 0.3 110.723 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.429 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 5.4 t -77.57 -38.09 49.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 0.34 111.678 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.15 -28.45 44.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.29 110.773 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -66.5 -28.14 68.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.093 -0.503 . . . . 1.81 111.184 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -97.27 -34.22 11.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.729 0.299 . . . . 1.24 111.276 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.0 mt -74.01 -30.75 62.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.86 0.318 . . . . 0.23 111.86 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 tp -52.18 -57.47 15.13 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 112.68 0.622 . . . . 0.36 112.68 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.91 -6.67 17.58 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.899 1.733 . . . . 0.12 113.313 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -97.44 -54.77 6.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 0.16 110.537 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -68.55 -29.95 68.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 0.27 111.407 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.6 m -74.9 -28.62 60.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.935 0.398 . . . . 0.23 110.376 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -77.53 -41.33 39.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.504 . . . . 1.59 109.943 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.08 -48.71 19.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.39 111.704 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -110.96 -64.1 1.32 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.868 0.366 . . . . 1.02 110.982 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 110.28 12.35 17.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.568 -0.825 . . . . 0.27 112.785 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.3 mt -113.6 -6.29 13.39 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 122.543 -0.387 . . . . 1.39 111.59 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.694 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 10.0 t 34.57 84.43 0.18 Allowed Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 124.303 1.041 . . . . 1.04 113.737 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' HG12 ' A' ' 38' ' ' VAL . 42.3 Cg_endo -68.9 -29.97 27.26 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.227 1.951 . . . . 0.71 112.081 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.5 pm0 -66.2 -28.86 69.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.32 111.033 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -70.29 -7.06 39.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.086 0.469 . . . . 1.12 110.314 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.4 t -111.26 -61.28 2.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.993 -0.549 . . . . 0.16 110.902 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 34' ' ' PRO . 10.0 p -67.74 -45.86 83.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 113.159 0.8 . . . . 0.2 113.159 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.64 -43.04 81.25 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.04 -0.412 . . . . 0.19 111.013 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -64.49 -47.07 90.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.06 -0.518 . . . . 0.34 110.615 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.45 82.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.12 111.665 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.8 m -63.88 -38.68 91.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 0.5 110.764 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.702 ' O ' ' HB2' ' A' ' 48' ' ' GLN . 47.7 t60 -76.34 -46.47 27.43 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.693 -0.484 . . . . 0.61 109.693 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.44 -49.06 75.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 2.72 111.508 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.0 100.84 0.56 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.803 -0.713 . . . . 0.41 111.903 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.31 -79.66 0.3 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.559 -0.829 . . . . 0.27 112.59 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' HIS . 68.9 mmtt -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.705 0.261 . . . . 1.71 111.705 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 37.7 tt0 -61.86 -20.32 63.57 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.749 0.309 . . . . 0.84 110.685 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.29 -11.71 59.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.29 111.107 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.22 -35.57 5.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.052 -0.522 . . . . 0.99 110.667 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 47' ' ' LYS . 43.0 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.616 -0.707 . . . . 1.44 111.326 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.934 0.397 . . . . 1.52 110.444 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' HG3' ' H ' ' A' ' 5' ' ' ALA . 13.2 pt20 -70.95 163.17 28.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.814 -0.63 . . . . 1.0 110.361 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -57.96 -38.07 64.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 0.29 111.778 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 t -68.6 -35.71 71.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.917 0.389 . . . . 1.1 110.815 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.51 ' H ' ' HG3' ' A' ' 2' ' ' GLN . . . -64.06 -36.15 83.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.178 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.71 -45.28 99.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.02 0.438 . . . . 0.36 110.259 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.97 -37.66 72.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.53 110.512 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 23.0 m -67.9 -30.13 69.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.971 -0.558 . . . . 0.42 111.143 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.6 -38.88 90.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.151 0.501 . . . . 0.48 109.711 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.99 -33.39 60.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.583 -0.735 . . . . 0.99 109.801 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.64 -2.74 90.63 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.719 -0.673 . . . . 0.52 112.617 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.75 -54.26 4.64 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.148 -0.549 . . . . 0.26 112.639 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -76.7 78.75 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.313 -0.254 . . . . 0.64 110.313 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 15.3 tt0 -55.29 -36.49 66.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.504 0.557 . . . . 1.51 112.504 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.45 -42.64 15.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.32 0.489 . . . . 0.22 112.32 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 19' ' ' VAL . 59.9 mt -73.72 -38.09 64.93 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 20' ' ' GLN . 2.5 tp10 -70.19 -35.26 73.81 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.826 -0.349 . . . . 0.9 110.79 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -73.51 -35.9 65.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.584 -0.28 . . . . 0.19 111.475 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 16' ' ' LEU . 6.3 p -67.79 -25.15 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-O 120.866 0.365 . . . . 0.26 110.979 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 17' ' ' GLU . 13.2 mt-30 -71.15 -24.98 62.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.38 -0.373 . . . . 2.29 111.159 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -99.88 -31.12 11.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.472 -0.331 . . . . 1.49 111.271 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -76.79 -25.67 53.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.611 -0.268 . . . . 0.45 110.878 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 14.4 tp -56.41 -59.27 12.56 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.143 -0.481 . . . . 0.49 111.806 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 18.2 Cg_endo -59.59 -41.11 59.52 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.099 1.866 . . . . 0.43 112.632 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.8 t -60.65 -52.38 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.16 110.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -67.02 -31.04 71.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.853 -0.612 . . . . 0.36 111.21 -179.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' O ' ' HA2' ' A' ' 31' ' ' GLY . 0.6 OUTLIER -73.53 -29.68 62.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.058 0.456 . . . . 1.08 110.651 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -81.39 -43.88 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 0.41 110.353 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.67 -54.1 8.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 0.2 111.982 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -101.57 -48.98 4.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.59 0.233 . . . . 1.41 111.469 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 27' ' ' CYS . . . 112.78 -54.02 0.57 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.538 -0.839 . . . . 0.34 112.654 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.84 73.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.846 0.313 . . . . 0.46 111.846 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 26' ' ' LEU . 8.9 t 41.63 81.3 0.25 Allowed Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 122.089 0.947 . . . . 0.27 112.11 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' O ' HG12 ' A' ' 38' ' ' VAL . 12.2 Cg_exo -71.59 -0.0 7.61 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.294 2.663 . . . . 0.17 112.45 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 23.1 mm-40 -61.37 -35.5 77.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.055 0.455 . . . . 0.32 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.17 1.45 13.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.24 110.628 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.0 -64.03 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 116.07 -0.513 . . . . 0.31 110.598 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -66.92 -47.28 82.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.563 0.579 . . . . 0.13 112.563 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -67.52 -41.3 84.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.14 111.146 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.9 mm -66.95 -47.15 83.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.176 -0.465 . . . . 0.23 110.703 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.97 94.73 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.503 -0.317 . . . . 0.23 111.171 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -68.69 -28.84 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.091 0.472 . . . . 0.2 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -72.05 -41.8 67.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.024 -0.535 . . . . 0.53 110.58 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.89 -29.08 27.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.91 110.917 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.72 106.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.849 -0.614 . . . . 0.34 111.585 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.58 -51.06 0.85 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.87 -0.681 . . . . 0.5 111.543 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -98.5 32.67 2.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.81 110.288 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -111.28 -9.6 14.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.795 -0.639 . . . . 0.78 110.59 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.69 5.9 13.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.835 -0.62 . . . . 0.65 110.828 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.89 -51.62 3.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.087 -0.506 . . . . 0.47 110.286 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.604 -0.713 . . . . 0.76 110.187 179.551 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 121.299 0.571 . . . . 1.31 110.102 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -85.62 150.72 24.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.869 -0.605 . . . . 1.52 110.062 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -58.41 -33.2 47.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.41 111.463 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 21' ' ' ARG . 33.1 m -71.78 -30.57 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.88 0.371 . . . . 0.43 110.728 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.55 -45.74 29.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.16 110.253 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 75.8 mt -55.66 -48.93 77.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.23 110.656 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.143 -0.481 . . . . 0.23 110.618 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 70.3 m -66.78 -37.88 85.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.867 -0.606 . . . . 0.24 111.377 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.81 -24.06 64.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.125 -0.489 . . . . 1.78 111.033 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.6 mt -85.93 -43.22 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.351 -0.386 . . . . 0.29 110.254 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.96 2.35 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.845 -0.693 . . . . 0.34 112.507 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.75 -19.66 4.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.823 -0.703 . . . . 0.22 112.724 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.08 95.21 5.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.636 -0.331 . . . . 0.42 110.153 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 59.6 mm-40 -54.48 -32.73 58.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.472 -0.785 . . . . 0.58 112.235 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.62 -47.1 13.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.265 0.468 . . . . 0.93 112.265 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -69.35 -40.32 77.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.492 0.552 . . . . 0.56 112.492 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.38 -37.02 74.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.818 0.342 . . . . 0.23 111.117 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -71.25 -43.03 68.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.505 -0.316 . . . . 0.18 111.437 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.25 -36.72 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 121.09 -0.244 . . . . 0.13 111.458 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -70.56 -29.68 66.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.991 0.424 . . . . 2.3 110.774 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -82.17 -32.19 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.057 -0.52 . . . . 0.47 111.582 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -89.25 -16.07 32.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.848 0.314 . . . . 0.42 111.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.436 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 8.0 tp -53.05 -53.66 52.95 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.356 -0.384 . . . . 0.37 111.973 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 Cg_endo -65.63 -9.72 23.71 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.097 1.865 . . . . 0.1 112.919 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.67 -52.76 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.991 0.424 . . . . 0.05 110.093 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.288 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 p -71.39 -18.37 62.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.079 0.466 . . . . 0.25 110.202 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -97.27 -43.15 7.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.951 -0.568 . . . . 0.77 110.284 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.62 -30.63 63.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.65 111.822 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -126.82 -53.33 1.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.713 0.292 . . . . 0.56 111.057 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.96 -21.89 42.52 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.587 -0.816 . . . . 0.28 112.993 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.0 tp -70.78 -12.57 61.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.554 0.216 . . . . 0.18 111.544 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 1.4 p 47.99 66.77 5.23 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.302 0.641 . . . . 0.37 111.676 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 38' ' ' VAL . 92.9 Cg_endo -83.21 -14.99 8.06 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.427 2.085 . . . . 0.29 112.266 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -60.43 -58.01 10.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.27 110.821 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -64.66 -13.4 53.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.274 -0.421 . . . . 0.82 111.624 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.88 -30.16 5.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.633 -0.258 . . . . 0.57 111.061 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 34' ' ' PRO . 14.7 p -104.62 -43.51 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 112.377 0.51 . . . . 0.36 112.377 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.96 80.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.768 0.318 . . . . 0.14 111.313 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.09 -38.38 82.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.966 0.412 . . . . 0.16 109.961 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.03 -17.06 63.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.88 -0.6 . . . . 0.22 111.27 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.6 m -81.46 -37.57 27.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.835 -0.431 . . . . 0.39 109.835 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -85.69 -57.34 3.09 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.055 -0.52 . . . . 0.77 110.892 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.04 15.7 3.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.898 0.38 . . . . 0.35 111.758 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.73 26.17 2.65 Favored Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 111.331 -0.708 . . . . 0.21 111.331 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.01 -66.37 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.65 -0.786 . . . . 0.31 112.756 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.86 58.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.171 0.51 . . . . 1.61 111.672 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -131.78 -21.13 2.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.787 -0.642 . . . . 0.63 109.755 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.62 2.15 38.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.585 . . . . 0.53 110.1 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.98 2.58 35.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.743 -0.662 . . . . 0.46 110.949 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.961 -0.543 . . . . 1.69 110.208 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.805 0.336 . . . . 1.31 110.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -140.16 159.96 41.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.835 -0.62 . . . . 1.52 109.508 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.11 -32.86 51.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.41 111.223 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 18' ' ' THR . 16.7 m -70.15 -30.93 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.43 111.187 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.85 -44.48 15.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.16 110.895 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 91.0 mt -58.96 -41.88 84.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.23 110.434 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.81 -45.89 91.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.23 110.524 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -65.84 -28.62 69.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.106 -0.497 . . . . 0.24 111.286 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.72 -42.47 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.075 -0.512 . . . . 1.78 110.767 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.2 mt -82.98 -33.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 0.29 110.869 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.07 -63.33 2.56 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.139 -0.553 . . . . 0.34 112.315 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.88 -26.08 6.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.596 -0.811 . . . . 0.22 112.815 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.73 102.29 11.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.987 0.423 . . . . 0.42 110.325 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -57.12 -48.35 78.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.825 -0.625 . . . . 0.58 111.463 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.66 6.37 6.05 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.2 0.815 . . . . 0.93 113.2 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -123.03 -37.18 2.75 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.691 -0.404 . . . . 0.56 111.309 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -41.82 46.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.191 0.52 . . . . 0.23 110.097 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 4' ' ' VAL . 90.5 m -67.95 -38.64 83.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.848 -0.615 . . . . 0.18 111.458 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.63 -33.81 65.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.994 -0.282 . . . . 0.13 111.073 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -70.03 -34.56 73.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.175 0.512 . . . . 2.3 110.515 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -76.92 -34.82 57.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.928 -0.578 . . . . 0.47 111.691 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -88.9 -15.32 34.66 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.345 0.498 . . . . 0.42 112.345 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 28.4 tp -55.35 -56.09 32.72 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 119.533 -0.27 . . . . 0.37 111.546 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.595 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 37.9 Cg_endo -65.66 -3.51 8.07 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.942 . . . . 0.1 112.942 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -95.36 -54.75 6.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.087 0.47 . . . . 0.05 109.997 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.92 -33.29 70.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.975 -0.557 . . . . 0.37 111.089 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 13.2 p -74.08 -19.65 60.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.409 . . . . 0.25 110.454 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -86.26 -44.91 11.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.167 -0.47 . . . . 0.77 110.59 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.08 -39.03 63.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.263 -0.426 . . . . 0.65 111.156 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -116.86 -73.25 0.65 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.417 -0.356 . . . . 0.56 110.801 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.0 -21.05 10.45 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.644 -0.788 . . . . 0.28 112.664 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.3 tp -63.94 -15.57 59.47 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.349 0.259 . . . . 0.18 111.569 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 22.8 p 49.41 65.97 6.3 Favored Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 123.325 0.65 . . . . 0.37 111.579 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' O ' HG12 ' A' ' 38' ' ' VAL . 89.3 Cg_endo -84.37 -9.85 9.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.66 2.24 . . . . 0.29 112.248 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -63.47 -58.35 7.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.27 109.635 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -28.57 69.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.82 111.143 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.93 -41.01 91.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.57 111.37 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -97.9 -41.58 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.698 0.629 . . . . 0.36 112.698 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.77 -53.67 50.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.888 0.329 . . . . 0.14 111.888 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.64 -38.33 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.75 -0.205 . . . . 0.16 110.673 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.48 -30.44 71.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.22 111.131 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.9 m -80.56 -18.23 49.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.861 0.362 . . . . 0.39 110.617 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -95.68 -61.83 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 0.77 110.639 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -79.94 5.05 14.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.36 -0.382 . . . . 0.35 111.292 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.0 21.96 3.3 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.144 -0.783 . . . . 0.21 111.144 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -169.95 -80.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.16 -0.543 . . . . 0.31 111.749 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -78.32 60.44 2.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.364 0.602 . . . . 1.61 109.952 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -117.66 -36.04 3.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.63 110.004 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 8.42 24.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.965 -0.562 . . . . 0.53 110.318 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.42 10.4 27.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 0.46 109.903 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.769 -0.634 . . . . 1.69 109.77 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.932 0.396 . . . . 1.0 110.101 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.415 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 1.1 pm0 -81.87 167.95 18.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.807 -0.633 . . . . 0.6 110.932 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 m -54.19 -42.16 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.584 0.587 . . . . 0.51 112.584 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -66.65 -19.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 111.725 0.269 . . . . 0.43 111.725 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.19 -34.8 14.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.028 0.442 . . . . 0.49 110.811 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 70.1 mt -73.02 -44.7 56.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.59 110.422 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.7 87.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.26 111.217 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 6.1 p -75.88 -31.02 59.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.441 -0.345 . . . . 0.31 111.274 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.28 -35.13 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.34 110.419 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 mm -87.76 -42.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.953 -0.567 . . . . 0.58 110.595 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.6 -45.21 86.78 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.043 -0.599 . . . . 0.45 113.049 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.76 -7.67 49.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.62 112.372 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 22.9 mtmm -120.16 97.81 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.654 -0.499 . . . . 0.89 109.654 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 2.2 mt-30 -62.83 -51.23 67.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.419 0.526 . . . . 2.43 112.419 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.88 70.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.384 0.513 . . . . 0.26 112.384 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' O ' HG12 ' A' ' 19' ' ' VAL . 5.1 mt -80.66 -39.45 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.585 -0.446 . . . . 1.0 111.765 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -70.38 -35.41 73.48 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.612 -0.435 . . . . 1.45 110.009 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.69 -34.24 67.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.089 -0.505 . . . . 0.35 111.171 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 16' ' ' LEU . 8.9 p -73.57 -29.63 27.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 122.11 -0.369 . . . . 0.15 110.685 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -79.39 -34.61 41.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.58 110.269 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -78.65 -37.31 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.02 -0.536 . . . . 1.18 111.2 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -83.65 -8.64 59.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.545 0.212 . . . . 0.11 111.448 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 2.1 tt -60.44 -56.86 31.18 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.429 -0.35 . . . . 1.03 111.492 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.4 Cg_endo -64.69 -13.82 41.22 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.151 1.901 . . . . 0.26 112.325 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -86.87 -53.29 10.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.275 0.559 . . . . 0.35 110.057 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.6 mm? -68.22 -30.59 69.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.711 -0.677 . . . . 0.21 111.644 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 14.8 p -76.2 -23.92 54.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.873 0.368 . . . . 0.24 110.316 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -87.95 -43.67 11.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.061 0.458 . . . . 0.34 110.438 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.05 67.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.1 -0.5 . . . . 0.35 111.462 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -121.57 -59.88 1.65 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.919 0.39 . . . . 0.63 110.863 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.28 -22.36 15.72 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.979 -0.629 . . . . 0.52 111.788 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.84 -32.63 63.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.237 . . . . 0.69 111.615 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 m 57.27 66.84 2.78 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 116.041 -0.527 . . . . 0.62 111.093 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' O ' HG12 ' A' ' 38' ' ' VAL . 33.2 Cg_endo -64.71 -22.51 64.08 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.697 2.265 . . . . 0.26 112.749 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 35.3 mm-40 -59.79 -28.57 67.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.389 -0.369 . . . . 0.36 110.931 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.37 -6.03 37.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.234 0.54 . . . . 0.49 110.616 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.5 t -118.11 -64.71 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 116.104 -0.498 . . . . 0.43 110.656 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' PRO . 11.7 p -59.85 -46.7 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 112.714 0.635 . . . . 0.29 112.714 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 35' ' ' GLU . . . -72.65 -44.51 61.79 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.192 -0.317 . . . . 0.14 111.502 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.11 -47.46 92.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.203 -0.453 . . . . 0.07 111.553 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.62 98.38 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.609 0.226 . . . . 0.06 111.609 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -68.07 -24.57 65.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 0.33 111.278 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -81.26 -56.24 4.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.472 -0.331 . . . . 0.42 111.403 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -75.25 -46.3 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.013 0.375 . . . . 0.81 112.013 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.56 29.4 8.46 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.504 -0.855 . . . . 0.38 112.992 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.29 -86.52 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.289 -0.957 . . . . 0.51 112.861 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 51' ' ' GLU . 21.4 mtpt -82.16 35.72 0.44 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.424 0.527 . . . . 1.44 112.424 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -67.61 -55.57 12.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.661 -0.416 . . . . 0.65 110.464 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.6 -7.05 54.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.149 0.5 . . . . 0.64 111.107 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -98.32 -4.2 35.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.023 -0.535 . . . . 0.53 110.69 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 1.7 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.19 -0.91 . . . . 1.33 110.186 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.993 0.425 . . . . 1.51 110.48 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -74.11 174.16 9.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.822 -0.627 . . . . 0.85 110.996 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.31 -40.23 77.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.347 0.499 . . . . 0.49 112.347 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 m -73.26 -21.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.795 -0.362 . . . . 0.54 111.013 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.13 -49.54 15.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.794 0.33 . . . . 0.25 110.591 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.6 pt -65.18 -37.68 80.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.36 110.953 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.59 91.52 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.444 -0.344 . . . . 0.15 111.145 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 15.3 m -68.89 -39.01 79.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.14 111.368 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.45 -51.03 65.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.28 111.054 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.68 -29.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.107 0.479 . . . . 0.32 110.726 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.47 -40.16 55.04 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.041 -0.6 . . . . 0.39 112.074 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.21 -31.92 6.43 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.874 -0.679 . . . . 0.22 112.178 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 24.1 mtmm -93.54 80.32 4.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.779 -0.452 . . . . 0.39 109.779 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 19.2 mm-40 -51.33 -58.55 5.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.476 -0.784 . . . . 0.36 113.063 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 16.5 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.246 0.832 . . . . 0.32 113.246 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 13' ' ' LYS . 34.3 mt -124.97 -35.01 2.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.566 -0.454 . . . . 1.7 111.235 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 11.2 tp10 -72.04 -35.22 69.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.844 0.354 . . . . 0.77 110.11 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -60.79 -46.95 88.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.29 111.118 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.75 -32.19 51.25 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 120.865 0.364 . . . . 0.45 110.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 20' ' ' GLN . 6.9 tp60 -69.56 -34.68 74.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.212 -0.449 . . . . 0.61 111.114 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -34.44 20.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.94 111.74 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.98 -12.58 55.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.628 0.233 . . . . 0.75 111.628 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.9 tp -54.3 -59.36 10.35 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 111.85 0.315 . . . . 0.36 111.85 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.35 -25.48 80.26 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.154 1.903 . . . . 0.39 112.659 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.26 -55.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.17 111.126 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.9 mm? -67.87 -32.96 73.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.48 111.491 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 81.1 m -68.04 -36.09 79.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.62 110.944 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -82.13 -29.77 31.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.219 0.533 . . . . 0.99 110.378 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -55.86 5.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.59 112.051 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -123.66 -33.09 3.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.243 0.461 . . . . 0.85 112.243 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 23.92 25.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.482 -0.866 . . . . 0.5 112.773 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 tp -117.33 -63.08 1.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.756 -0.261 . . . . 1.48 110.653 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.468 HG22 ' HG2' ' A' ' 35' ' ' GLU . 7.0 m 68.29 80.88 0.21 Allowed Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.539 0.524 . . . . 0.76 110.901 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.72 -26.77 83.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.097 2.532 . . . . 0.55 114.067 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG22 ' A' ' 33' ' ' THR . 2.1 pm0 -62.89 -22.67 66.89 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.356 -0.215 . . . . 1.34 111.366 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.27 -4.27 24.95 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.857 0.36 . . . . 1.22 110.945 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -117.84 -64.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.892 0.377 . . . . 0.14 110.861 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.82 -52.84 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.264 0.839 . . . . 0.15 113.264 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.25 -42.89 99.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.888 0.375 . . . . 0.09 111.558 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.4 mm -62.54 -49.9 81.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.019 -0.537 . . . . 0.27 110.613 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.7 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.907 0.336 . . . . 0.15 111.907 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.0 m -60.93 -33.48 73.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.363 . . . . 0.23 111.74 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -87.56 -41.59 13.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.014 0.376 . . . . 0.54 112.014 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.27 -40.46 51.69 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.911 0.337 . . . . 0.84 111.911 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.86 -9.78 58.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.429 -0.891 . . . . 1.05 112.916 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.56 -73.37 0.35 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.982 -1.104 . . . . 0.63 113.435 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -76.77 30.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.387 0.884 . . . . 0.67 113.387 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -90.49 -37.34 13.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.127 0.489 . . . . 1.15 109.919 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.54 -18.53 23.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.053 -0.522 . . . . 0.81 110.198 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -79.56 -44.48 21.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.586 -0.734 . . . . 0.46 111.274 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.566 -0.731 . . . . 1.75 110.74 -179.7 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.91 0.386 . . . . 1.3 110.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -83.47 174.18 10.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.67 110.776 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG23 HG13 ' A' ' 4' ' ' VAL . 31.1 m -59.42 -36.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.57 111.986 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 3' ' ' VAL . 33.0 m -88.76 20.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 0.65 111.187 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.84 -52.19 1.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.977 -0.556 . . . . 0.39 110.357 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 24.2 pt -59.98 -33.41 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.15 -0.477 . . . . 0.59 111.985 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.95 -31.1 17.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.891 0.377 . . . . 0.45 111.643 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB3' ' HA ' ' A' ' 14' ' ' GLN . 1.6 m -78.02 -48.51 15.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.097 0.406 . . . . 0.18 112.097 -178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.3 -46.23 70.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.35 110.836 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 1.7 mp -69.73 -29.01 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 1.28 110.375 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 0.1 82.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.021 -0.609 . . . . 0.24 112.035 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.57 -50.92 4.33 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.41 -0.424 . . . . 0.17 112.813 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 16' ' ' LEU . 6.5 mtmt -82.7 69.4 9.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.719 0.295 . . . . 0.5 110.738 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 8' ' ' SER . 50.5 tt0 -59.61 -46.27 89.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.144 -0.48 . . . . 0.3 111.634 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -79.32 12.06 2.59 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.486 0.55 . . . . 0.39 112.486 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 13' ' ' LYS . 58.5 mt -124.21 -43.68 2.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.835 0.35 . . . . 1.42 110.729 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 55.7 mm-40 -68.35 -32.22 72.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.746 0.307 . . . . 0.51 110.809 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -64.32 -36.78 85.25 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.414 -0.357 . . . . 0.42 111.416 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.96 -35.2 14.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 121.02 -0.272 . . . . 1.29 110.451 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -68.93 -36.98 78.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.277 0.561 . . . . 0.84 110.579 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.453 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -73.84 -35.78 64.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.652 -0.704 . . . . 1.15 111.486 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HG ' HG11 ' A' ' 4' ' ' VAL . 28.2 mt -89.56 -7.22 55.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.812 0.301 . . . . 0.35 111.812 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -58.96 -60.17 11.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 119.191 -0.433 . . . . 0.78 111.764 -179.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 23' ' ' LEU . 24.2 Cg_endo -60.48 -35.65 89.66 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.769 1.646 . . . . 0.35 112.037 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.74 -54.99 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.38 110.563 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.18 -34.02 76.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.32 111.392 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 66.3 m -64.11 -41.0 97.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.506 -0.315 . . . . 0.51 111.086 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -81.75 -37.92 26.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.637 0.256 . . . . 0.76 111.025 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.13 -50.68 73.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.168 -0.469 . . . . 0.47 111.832 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.28 -19.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.185 0.439 . . . . 2.04 112.185 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 83.68 22.8 55.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.298 -0.954 . . . . 0.36 112.499 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.95 -58.35 1.96 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.824 0.345 . . . . 2.0 110.809 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 2.8 m 57.92 66.01 3.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.566 -0.743 . . . . 0.6 111.975 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.47 -10.27 25.18 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.157 1.905 . . . . 0.19 111.421 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' GLU . 2.6 mm-40 -58.12 -38.58 76.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.275 -0.875 . . . . 1.32 110.593 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 33' ' ' THR . 4.4 pt20 -74.21 -7.47 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.52 111.444 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.5 -24.39 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.578 -0.283 . . . . 0.6 111.049 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.2 p -104.11 -45.45 9.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.178 0.436 . . . . 0.64 112.178 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 -46.57 55.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.889 0.376 . . . . 0.26 111.363 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.18 -38.31 81.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.295 -0.412 . . . . 1.19 110.266 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.65 78.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.911 -0.586 . . . . 0.31 111.683 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.4 p -68.27 -38.43 81.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.95 111.112 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.434 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 50.0 t60 -66.68 -45.01 80.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.83 110.828 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -74.41 -44.67 50.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.339 -0.391 . . . . 0.67 111.045 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.91 106.28 1.01 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.863 -0.684 . . . . 0.44 111.969 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.57 -69.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.497 -0.859 . . . . 0.22 112.24 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -32.08 71.92 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.519 0.2 . . . . 0.36 110.893 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -62.17 -26.97 68.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.925 0.393 . . . . 1.03 110.61 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -87.09 -1.95 58.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.65 110.818 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.2 mm? -110.36 -34.51 6.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.802 -0.635 . . . . 0.48 109.987 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.25 1.109 0 CA-C-N 115.307 -0.86 . . . . 1.32 110.468 -179.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.586 0.232 . . . . 2.19 110.7 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -150.03 153.29 36.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.02 -0.363 . . . . 1.9 110.02 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' HA ' HG12 ' A' ' 6' ' ' ILE . 4.5 m -59.8 -33.82 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 123.272 0.357 . . . . 0.41 111.939 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.54 -8.99 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.442 -0.345 . . . . 0.65 111.724 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.92 -41.26 6.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.26 111.28 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 3' ' ' VAL . 29.9 pt -65.31 -31.45 53.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.094 0.473 . . . . 0.27 110.343 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.71 83.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.958 -0.565 . . . . 0.2 110.734 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.29 -34.12 67.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.526 . . . . 0.35 111.134 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -60.82 -43.11 98.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.031 -0.531 . . . . 0.71 110.355 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 mt -82.08 -35.67 13.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.29 110.435 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.71 -52.75 43.18 Favored Glycine 0 N--CA 1.453 -0.2 0 CA-C-N 115.981 -0.554 . . . . 0.16 112.17 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.4 -16.8 6.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.494 -0.86 . . . . 0.3 113.184 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -124.16 110.34 14.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.953 0.406 . . . . 0.65 110.89 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -75.84 -3.85 37.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 0.55 111.379 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -122.36 13.59 10.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.517 -0.31 . . . . 0.34 111.591 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 13' ' ' LYS . 7.4 mt -126.74 -50.32 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.618 -0.265 . . . . 0.88 111.092 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.97 -36.03 83.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.365 0.602 . . . . 0.36 109.851 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.5 m -65.37 -54.2 32.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.389 -0.823 . . . . 1.23 111.275 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 35' ' ' GLU . 5.6 p -61.67 -34.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.57 -0.286 . . . . 0.27 111.081 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.91 -30.95 71.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.97 111.05 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -95.4 -17.78 21.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.45 -0.341 . . . . 0.58 111.209 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 69.9 mt -86.14 -30.55 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 0.1 110.859 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 46.9 tp -51.78 -53.91 45.8 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.811 -0.632 . . . . 0.7 112.318 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -65.32 -5.07 10.47 Favored 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.06 1.84 . . . . 0.36 112.806 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.72 -57.16 4.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.948 0.404 . . . . 0.16 110.418 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.88 -36.63 78.31 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.176 -0.466 . . . . 0.42 111.526 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -72.58 -21.8 61.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.049 0.452 . . . . 0.72 110.349 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.89 -41.81 15.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.21 -0.45 . . . . 0.79 110.128 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.0 -46.88 64.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.972 -0.558 . . . . 0.32 111.929 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -122.4 -49.1 2.05 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.074 -0.251 . . . . 0.65 111.479 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 100.29 11.49 41.9 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 120.339 -0.934 . . . . 0.08 112.967 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -98.72 -5.49 31.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.932 0.366 . . . . 0.65 111.475 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 31.23 76.32 0.37 Allowed Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.024 0.93 . . . . 0.2 113.148 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 38' ' ' VAL . 52.7 Cg_endo -70.39 -31.52 17.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.308 2.005 . . . . 0.13 112.024 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CG ' HG23 ' A' ' 19' ' ' VAL . 8.0 pm0 -60.12 -31.68 70.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.01 -0.541 . . . . 0.4 111.543 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -75.94 -13.68 60.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.941 0.348 . . . . 1.97 111.941 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.43 -13.85 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.305 -0.558 . . . . 0.24 112.181 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.7 p -113.78 -48.02 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 120.297 -0.561 . . . . 0.27 111.639 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.66 -48.37 48.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.18 110.147 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 19' ' ' VAL . 20.3 mm -60.95 -41.92 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 0.27 110.221 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.81 99.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.932 -0.576 . . . . 0.12 111.358 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.6 m -62.6 -34.4 76.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.411 . . . . 0.37 110.915 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 20.5 t60 -81.15 -37.54 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.507 -0.315 . . . . 0.7 110.491 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.86 -48.39 66.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.321 -0.4 . . . . 0.24 111.31 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.29 91.7 0.51 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.852 -0.69 . . . . 0.37 112.507 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.94 -73.93 0.39 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.732 . . . . 0.25 112.424 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 4.3 tptp -77.6 -3.13 39.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.741 0.305 . . . . 0.99 111.353 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -57.35 -42.62 82.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 0.2 111.399 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.09 17.76 16.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.196 0.522 . . . . 0.43 111.072 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.21 -32.41 3.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.029 -0.532 . . . . 0.63 111.023 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.372 -0.823 . . . . 1.02 110.165 -179.7 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.195 -0.298 . . . . 2.19 110.195 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 6' ' ' ILE . 15.3 pm0 -133.88 168.87 17.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.517 -0.31 . . . . 1.9 110.165 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -62.04 -36.34 73.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.317 . . . . 0.41 111.643 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' HB ' ' OG1' ' A' ' 18' ' ' THR . 35.0 m -81.49 15.18 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 0.65 111.285 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.54 -48.87 1.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.555 . . . . 0.26 110.648 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 2' ' ' GLN . 8.2 pt -64.63 -42.28 94.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.314 -0.403 . . . . 0.27 111.279 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.47 -43.11 98.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.2 110.602 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.403 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 0.7 OUTLIER -64.38 -34.81 79.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.837 -0.62 . . . . 0.35 111.016 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -63.12 -36.34 83.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.727 -0.669 . . . . 0.71 110.387 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -82.77 -40.18 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.29 110.449 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.84 99.8 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 116.041 -0.527 . . . . 0.16 112.48 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.92 -30.27 7.23 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.9 -0.667 . . . . 0.3 112.654 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -104.65 102.49 12.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.403 0.621 . . . . 0.65 110.684 -179.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.56 -29.49 70.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.117 -0.947 . . . . 0.55 112.506 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.17 -4.43 29.6 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.245 0.831 . . . . 0.34 113.245 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 13' ' ' LYS . 46.1 mt -107.46 -41.99 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.429 -0.508 . . . . 0.88 111.735 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -70.48 -24.18 62.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.007 0.432 . . . . 0.36 110.568 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB ' ' A' ' 4' ' ' VAL . 1.8 t -79.35 -37.45 37.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.23 111.522 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG11 HD11 ' A' ' 40' ' ' ILE . 8.2 p -70.98 -35.15 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 O-C-N 122.109 -0.369 . . . . 0.27 111.351 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -64.92 -24.89 67.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.97 111.116 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.411 ' HB3' HG12 ' A' ' 4' ' ' VAL . 12.8 tpp85 -97.4 -27.79 14.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.164 -0.471 . . . . 0.58 111.258 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.8 mt -80.9 -37.76 29.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.726 0.269 . . . . 0.1 111.726 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -47.53 -54.09 25.09 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 112.942 0.719 . . . . 0.7 112.942 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 27.1 Cg_endo -60.84 -22.04 72.54 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.969 1.779 . . . . 0.36 113.141 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.6 -48.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.057 0.456 . . . . 0.16 110.683 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.1 mm? -68.73 -31.23 70.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.999 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 67.8 m -79.27 -18.67 52.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.72 111.015 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 40.7 tt0 -84.94 -33.51 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.978 0.418 . . . . 0.79 110.693 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.2 -23.23 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.234 0.457 . . . . 0.32 112.234 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -132.48 -68.84 0.6 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.677 0.275 . . . . 0.65 111.224 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 27' ' ' CYS . . . 108.73 13.97 16.98 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.315 -0.945 . . . . 0.08 113.102 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.68 -12.86 15.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.127 0.464 . . . . 0.65 110.884 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.516 ' HB ' ' SG ' ' A' ' 27' ' ' CYS . 9.3 t 38.18 80.32 0.28 Allowed Pre-proline 0 CA--C 1.542 0.639 0 O-C-N 124.272 0.982 . . . . 0.2 112.675 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.55 ' O ' HG12 ' A' ' 38' ' ' VAL . 29.4 Cg_endo -64.89 -34.63 47.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.536 2.157 . . . . 0.13 112.38 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 3.2 pm0 -62.43 -27.93 69.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.944 0.402 . . . . 0.4 111.148 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -70.25 -27.71 64.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.733 0.301 . . . . 1.97 110.928 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -100.67 -24.25 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.539 0.57 . . . . 0.24 112.539 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' PRO . 12.1 p -108.17 -50.31 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 112.704 0.631 . . . . 0.27 112.704 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.58 -45.95 81.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.944 0.402 . . . . 0.18 110.663 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 HG11 ' A' ' 19' ' ' VAL . 25.1 mm -61.12 -41.28 88.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.028 -0.533 . . . . 0.27 109.706 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.74 -34.19 76.69 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.792 -0.64 . . . . 0.12 110.964 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -64.83 -48.92 72.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.37 110.291 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . 66.9 t60 -69.96 -36.23 75.09 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.7 110.287 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.46 -45.09 76.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.242 -0.436 . . . . 0.24 111.507 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.19 115.7 2.01 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.924 -0.655 . . . . 0.37 112.471 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.77 -65.65 0.26 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.965 -0.636 . . . . 0.25 112.309 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 43' ' ' HIS . 12.8 tppt? -78.73 -16.8 56.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.516 0.198 . . . . 0.99 111.036 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -55.26 -39.86 70.27 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.993 0.425 . . . . 0.2 111.411 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.49 3.41 54.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.368 -0.378 . . . . 0.43 111.778 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -122.4 13.18 10.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.026 0.441 . . . . 0.63 111.224 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.44 -0.79 . . . . 1.02 110.011 179.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.928 0.394 . . . . 1.23 110.747 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.716 ' H ' ' HB3' ' A' ' 5' ' ' ALA . 12.9 pt20 -161.19 -174.86 4.54 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.441 -0.948 . . . . 0.68 108.441 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.3 m -55.41 -39.63 53.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.665 0.617 . . . . 0.22 112.665 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 2' ' ' GLN . 5.1 m -76.38 -21.65 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.831 -0.348 . . . . 0.9 111.369 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' A' ' 2' ' ' GLN . . . -85.67 -36.3 20.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.734 0.302 . . . . 0.17 111.369 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.0 mt -67.3 -43.1 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.844 -0.428 . . . . 0.36 109.844 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.44 -39.36 93.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.547 . . . . 0.39 111.119 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 p -76.07 -25.29 55.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.73 111.021 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -67.19 -24.51 65.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.325 0.583 . . . . 0.87 109.875 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.4 mm -93.27 -37.49 8.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.601 -0.727 . . . . 0.35 110.447 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.32 -45.21 10.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.051 -0.595 . . . . 0.15 113.416 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.06 -8.36 53.66 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.011 -0.614 . . . . 0.24 112.648 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -121.11 93.67 4.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.5 110.251 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -61.23 -34.95 75.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.97 -0.559 . . . . 1.1 111.722 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 43' ' ' HIS . . . -80.53 1.5 29.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.626 0.602 . . . . 0.59 112.626 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.656 ' O ' HG12 ' A' ' 19' ' ' VAL . 7.2 mt -124.46 -41.52 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.656 0.265 . . . . 1.26 111.487 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.168 0.508 . . . . 0.88 110.395 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.4 m -70.91 -35.86 72.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.935 -0.575 . . . . 1.15 111.364 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.4 p -66.31 -22.46 30.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.849 0.357 . . . . 0.72 111.127 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -95.94 -14.62 22.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 2.27 110.945 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -93.5 -37.38 11.95 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.401 -0.363 . . . . 1.02 111.041 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.77 -20.18 26.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.88 0.326 . . . . 0.53 111.88 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 9.9 tp -53.87 -55.68 33.35 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 112.025 0.379 . . . . 0.33 112.025 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 36.5 Cg_endo -64.91 -11.03 27.58 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.191 1.927 . . . . 0.17 112.66 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.42 -51.56 11.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.001 0.429 . . . . 0.18 110.461 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.11 112.198 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 p -71.06 -31.53 67.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 0.13 110.547 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -14.66 22.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.64 111.489 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.01 -10.24 20.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 0.46 111.272 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -152.46 -60.72 0.15 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.383 -0.371 . . . . 0.65 110.252 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.29 -16.73 32.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.644 -0.789 . . . . 0.32 112.809 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.14 -24.87 51.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.506 0.153 . . . . 0.45 111.304 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.2 p 48.22 73.41 1.0 Allowed Pre-proline 0 N--CA 1.469 0.489 0 C-N-CA 123.231 0.612 . . . . 0.4 112.143 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . 53.0 Cg_endo -68.89 -8.33 23.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.612 2.208 . . . . 0.22 112.402 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.608 ' HB3' HG23 ' A' ' 19' ' ' VAL . 12.9 mp0 -55.65 -47.28 76.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.153 -0.476 . . . . 0.47 110.885 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -79.01 -5.39 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.297 -0.41 . . . . 0.47 111.103 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.5 t -99.51 -39.02 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.149 0.425 . . . . 0.24 112.149 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.2 p -106.3 -50.18 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.311 0.485 . . . . 0.46 112.311 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 -55.01 20.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.585 0.231 . . . . 0.43 111.136 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 19' ' ' VAL . 17.8 mm -60.65 -39.71 82.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.789 0.328 . . . . 0.69 110.937 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -48.64 80.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.5 m -70.67 -32.07 69.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.972 0.415 . . . . 0.46 110.597 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 20.9 t60 -66.97 -49.7 64.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.798 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.09 -47.15 18.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.282 -0.417 . . . . 0.58 111.039 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -99.18 70.67 0.55 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.015 -0.612 . . . . 0.13 112.497 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.35 -69.6 0.32 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.654 -0.784 . . . . 0.31 112.71 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 50' ' ' LEU . 13.4 tptp -62.5 -20.39 64.55 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.638 0.256 . . . . 0.93 110.893 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -58.49 -36.66 74.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.765 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.18 -17.16 31.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.51 110.939 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.3 mm? -87.93 -35.82 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.13 -0.486 . . . . 1.42 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 C--O 1.246 0.915 0 CA-C-N 115.625 -0.716 . . . . 1.72 110.214 -179.354 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 109.986 -0.376 . . . . 1.35 109.986 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -163.88 162.19 23.43 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.197 -0.297 . . . . 1.49 110.197 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 m -54.04 -39.05 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.16 112.088 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.6 m -65.47 -31.98 56.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.2 111.103 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.72 -42.77 16.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 0.09 110.879 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.6 mt -58.91 -49.96 81.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.36 -0.382 . . . . 0.05 110.559 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.22 98.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.111 -0.495 . . . . 0.11 110.755 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 14' ' ' GLN . 73.9 m -67.1 -37.9 84.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.182 -0.463 . . . . 0.09 111.549 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.43 -43.94 92.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.894 0.378 . . . . 0.78 110.826 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -77.44 -34.98 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.226 -0.443 . . . . 0.24 110.79 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.01 -51.47 18.47 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.884 -0.674 . . . . 0.12 112.354 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.34 -5.19 38.19 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.898 -0.668 . . . . 0.22 112.645 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.1 87.64 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.983 -0.377 . . . . 0.37 109.983 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.476 ' HG2' ' HB3' ' A' ' 8' ' ' SER . 43.4 mt-30 -50.0 -54.93 16.82 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.21 68.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.12 0.785 . . . . 0.61 113.12 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.9 mt -88.59 -37.2 15.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.753 0.311 . . . . 0.56 111.8 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.24 -35.9 61.35 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.079 0.466 . . . . 0.24 110.681 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.9 m -68.37 -41.8 80.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.377 -0.374 . . . . 1.05 111.426 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HB2' ' A' ' 23' ' ' LEU . 11.0 p -64.49 -35.46 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.839 -0.164 . . . . 0.17 111.353 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -72.83 -21.8 60.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.41 111.083 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -93.48 -42.31 9.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.106 -0.497 . . . . 0.85 111.716 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.0 mt -78.67 -24.1 45.33 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.368 0.507 . . . . 0.35 112.368 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.7 OUTLIER -53.72 -57.71 16.27 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 119.481 -0.295 . . . . 0.54 111.679 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.18 -35.07 87.56 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 121.964 1.776 . . . . 0.08 111.881 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.24 -48.29 88.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.962 -0.563 . . . . 0.18 110.447 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -24.69 60.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.111 -0.495 . . . . 0.6 110.894 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 59.0 m -67.28 -41.37 85.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.828 -0.434 . . . . 0.77 109.828 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -29.79 53.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.077 -0.51 . . . . 1.2 110.186 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.72 -53.45 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.637 . . . . 0.29 111.426 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -123.66 -53.08 1.79 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.65 0.262 . . . . 0.49 111.263 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.71 -20.02 12.18 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.483 -0.865 . . . . 0.13 112.755 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.48 -35.59 46.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.987 -0.126 . . . . 0.88 110.784 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t 39.99 81.61 0.24 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 122.105 0.955 . . . . 0.25 112.721 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 38' ' ' VAL . 65.4 Cg_endo -75.23 0.43 9.0 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.21 112.149 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -60.03 -35.1 74.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.26 109.953 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.57 -3.45 14.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.636 . . . . 0.26 110.841 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.62 -58.94 3.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.157 -0.474 . . . . 0.07 110.455 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.5 p -65.14 -44.99 95.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 112.77 0.656 . . . . 0.3 112.77 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.73 69.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.771 0.32 . . . . 0.32 111.142 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.3 mm -67.23 -44.6 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.31 110.689 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.71 -43.27 94.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.2 110.719 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.7 m -68.46 -21.47 64.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.931 -0.577 . . . . 0.33 110.931 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 38.6 t60 -87.85 -44.82 10.8 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.597 0.237 . . . . 1.04 110.687 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.78 -56.25 4.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.251 0.463 . . . . 1.61 112.251 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.7 -13.95 53.97 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.418 -0.896 . . . . 0.48 113.712 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.97 -57.93 1.36 Allowed Glycine 0 C--N 1.319 -0.371 0 C-N-CA 120.085 -1.055 . . . . 0.65 113.228 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 43' ' ' HIS . 5.6 mmpt? -59.13 -33.06 70.44 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.648 0.61 . . . . 0.89 112.648 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.48 -10.53 45.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.018 0.377 . . . . 2.08 112.018 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.09 4.55 39.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.017 0.437 . . . . 0.81 110.486 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.87 -45.77 1.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.794 -0.639 . . . . 1.43 110.195 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.609 -0.71 . . . . 1.77 109.646 179.969 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.682 0.277 . . . . 1.35 110.483 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -167.44 153.19 7.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.769 -0.456 . . . . 1.49 109.769 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -56.3 -36.31 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 112.171 0.434 . . . . 0.16 112.171 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -23.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.944 0.402 . . . . 0.2 111.008 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.98 -44.5 8.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.286 -0.415 . . . . 0.09 110.474 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 82.0 mt -58.78 -47.9 87.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.05 110.408 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.37 80.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.11 110.508 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.417 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 38.5 m -71.22 -41.25 70.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.93 -0.577 . . . . 0.09 111.216 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -63.13 -40.52 97.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.958 0.409 . . . . 0.78 110.466 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.1 mm -77.13 -43.13 31.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.041 -0.527 . . . . 0.24 110.622 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.82 -48.55 65.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.137 -0.554 . . . . 0.12 112.805 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.49 -20.83 22.49 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.942 -0.647 . . . . 0.22 112.455 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -116.64 91.69 3.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.044 0.449 . . . . 0.37 110.52 -179.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' CB ' ' A' ' 8' ' ' SER . 40.0 mt-30 -55.76 -47.0 77.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.92 112.199 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 43' ' ' HIS . . . -77.79 7.93 5.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.544 0.572 . . . . 0.61 112.544 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HG12 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -123.76 -34.1 3.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.055 0.455 . . . . 0.56 110.318 179.164 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.57 -29.57 41.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.344 -0.389 . . . . 0.24 110.447 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -71.63 -30.25 65.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.57 -0.286 . . . . 1.05 111.271 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' O ' ' A' ' 16' ' ' LEU . 9.4 p -71.79 -28.18 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 121.055 -0.258 . . . . 0.17 110.388 -179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -73.74 -21.02 60.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.125 0.488 . . . . 0.41 110.634 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -98.57 -38.12 9.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.5 . . . . 0.85 111.687 -179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.99 -29.48 43.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.266 0.469 . . . . 0.35 112.266 -178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 2.0 tp -53.43 -57.3 17.57 Favored Pre-proline 0 N--CA 1.468 0.441 0 N-CA-C 112.08 0.4 . . . . 0.54 112.08 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 23' ' ' LEU . 25.9 Cg_endo -61.53 -34.47 85.33 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.862 1.708 . . . . 0.08 112.528 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.97 -55.19 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.914 0.387 . . . . 0.18 110.616 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -67.41 -29.03 68.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.276 -0.42 . . . . 0.6 111.031 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -71.52 -28.37 63.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.77 110.406 179.23 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -86.11 -34.04 20.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.084 0.468 . . . . 1.2 110.374 179.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.99 -49.88 18.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.628 . . . . 0.29 111.537 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -119.87 -53.59 2.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 0.49 111.066 -179.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.77 -9.86 21.38 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.262 -0.97 . . . . 0.13 112.71 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 64.5 tp -86.63 -41.77 13.97 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.424 -0.11 . . . . 0.88 111.184 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.5 HG23 HE21 ' A' ' 36' ' ' GLN . 6.0 t 40.26 81.35 0.25 Allowed Pre-proline 0 CA--C 1.538 0.511 0 O-C-N 124.288 0.993 . . . . 0.25 112.153 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 38' ' ' VAL . 58.5 Cg_endo -71.05 -2.55 11.26 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.915 2.41 . . . . 0.21 112.58 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 19' ' ' VAL . 29.0 mp0 -59.57 -32.83 70.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.019 -0.537 . . . . 0.26 110.022 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.5 HE21 HG23 ' A' ' 33' ' ' THR . 9.7 pt20 -70.13 -6.27 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.26 110.796 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.32 -66.35 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.892 -0.594 . . . . 0.07 110.915 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 34' ' ' PRO . 7.6 p -62.76 -50.73 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 112.977 0.732 . . . . 0.3 112.977 -177.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 43' ' ' HIS . . . -67.38 -40.42 85.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.32 110.862 -178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.4 mm -66.6 -47.39 83.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.083 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.26 93.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.663 0.268 . . . . 0.2 110.773 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.4 m -68.78 -22.71 64.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.277 -0.419 . . . . 0.33 111.38 -179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -86.66 -30.41 21.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.783 0.325 . . . . 1.04 110.671 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 9.5 t0 -92.01 -82.98 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.369 -0.378 . . . . 1.61 111.559 -178.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 -17.96 79.77 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.087 -0.577 . . . . 0.48 113.452 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.87 -13.55 59.09 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.594 -0.813 . . . . 0.65 113.49 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -104.89 -4.87 21.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.125 0.462 . . . . 0.89 110.961 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 44' ' ' ASP . 56.1 mt-30 -56.21 -48.65 76.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.465 -0.334 . . . . 2.08 111.565 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.29 12.58 13.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.713 0.292 . . . . 0.81 111.446 -179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -127.83 31.94 5.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.43 110.222 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.191 -0.909 . . . . 1.77 110.324 -179.971 . . . . . . . . 0 0 . 1 stop_ save_